<SEC-DOCUMENT>0001193125-22-224115.txt : 20220818
<SEC-HEADER>0001193125-22-224115.hdr.sgml : 20220818
<ACCEPTANCE-DATETIME>20220818161058
ACCESSION NUMBER:		0001193125-22-224115
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220815
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220818
DATE AS OF CHANGE:		20220818

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMGEN INC
		CENTRAL INDEX KEY:			0000318154
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				953540776
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37702
		FILM NUMBER:		221177610

	BUSINESS ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320
		BUSINESS PHONE:		(805)447-1000

	MAIL ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMGEN
		DATE OF NAME CHANGE:	19870305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d280175d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amgn="http://www.amgen.com/20220815" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2022-08-15_to_2022-08-15">AMGEN INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-08-15_to_2022-08-15">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-08-15_to_2022-08-15">0000318154</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="amgn-20220815.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-08-15_to_2022-08-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-15</xbrli:startDate> <xbrli:endDate>2022-08-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-15</xbrli:startDate> <xbrli:endDate>2022-08-15</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-15</xbrli:startDate> <xbrli:endDate>2022-08-15</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-08-15_to_2022-08-15">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt:datemonthdayyearen">August&#160;15, 2022</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Amgen Inc.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-08-15_to_2022-08-15">001-37702</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-08-15_to_2022-08-15">95-3540776</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-08-15_to_2022-08-15">One Amgen Center Drive</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-08-15_to_2022-08-15">Thousand Oaks</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-08-15_to_2022-08-15">91320-1799</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-08-15_to_2022-08-15">(805)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-08-15_to_2022-08-15">447-1000</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common stock, $0.0001 par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">AMGN</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember">2.000% Senior Notes due 2026</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember">AMGN26</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-08-15_to_2022-08-15" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;1.01.&#160;&#160;Entry into a Material Definitive Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;text-align:justify">On August 18, 2022, Amgen Inc. (the &#8220;Company&#8221;) issued and sold $1,250,000,000 aggregate principal amount of the Company&#8217;s 4.050% Senior Notes due 2029 (the &#8220;2029 Notes&#8221;), $750,000,000 aggregate principal amount of the Company&#8217;s 4.200% Senior Notes due 2033 (the &#8220;2033 Notes&#8221;), and $1,000,000,000 aggregate principal amount of the Company&#8217;s 4.875% Senior Notes due 2053 (the &#8220;2053 Notes&#8221; and, together with the 2029 Notes and the 2033 Notes, the &#8220;Notes&#8221;). The Notes are registered under an effective Registration Statement on Form <span style="white-space:nowrap">S-3</span> (Registration <span style="white-space:nowrap">No.&#160;333-236351)</span> (the &#8220;Registration Statement&#8221;), filed on February&#160;10, 2020, and were issued pursuant to an indenture, dated as of May&#160;22, 2014 (the &#8220;Indenture&#8221;), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, and an officer&#8217;s certificate, dated as of August&#160;18, 2022 (the &#8220;Officer&#8217;s Certificate&#8221;), setting forth the terms of the Notes. Net proceeds to the Company from the offering were approximately $2,976,217,500, after deducting underwriters&#8217; discounts and estimated offering expenses payable by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The relevant terms of the Notes are set forth in the Indenture, included as Exhibit 4.1 of the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K,</span> filed on May&#160;22, 2014, and incorporated herein by reference, and the Officer&#8217;s Certificate (including the forms of the Notes) attached hereto as Exhibit 4.2 and incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2029 Notes will pay interest at the rate of 4.050% per annum, the 2033 Notes will pay interest at the rate of 4.200% per annum and the 2053 Notes will pay interest at the rate of 4.875% per annum, which, in the case of the 2029 Notes, shall be payable in cash semi-annually in arrears on February 18 and August 18 of each year, beginning on February 18, 2023 and, in the case of the 2033 Notes and 2053 Notes, shall be payable in cash semi-annually in arrears on March 1 and September 1 of each year, beginning March&#160;1,&#160;2023. The 2029 Notes will mature on August 18, 2029, the 2033 Notes will mature on March 1, 2033 and the 2053 Notes will mature on March 1, 2053. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a change in control triggering event, as defined in the Officer&#8217;s Certificate, the holders of the Notes may require the Company to purchase for cash all or a portion of their Notes at a purchase price equal to 101% of the principal amount of Notes, plus accrued and unpaid interest, if any. The descriptions of the Indenture, the Officer&#8217;s Certificate and the Notes in this report are summaries and are qualified in their entirety by the terms of the Indenture, the Officer&#8217;s Certificate and the Notes, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will rank equal in right of payment to all of the Company&#8217;s other existing and future senior unsecured indebtedness, senior in right of payment to all of the Company&#8217;s existing and future subordinated indebtedness, effectively subordinated in right of payment to all of the Company&#8217;s subsidiaries&#8217; obligations (including secured and unsecured obligations) and subordinated in right of payment to the Company&#8217;s secured obligations, to the extent of the assets securing such obligations. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01.&#160;&#160;Financial Statements and Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:14%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:85%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Exhibit&#160;No.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Document Description</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d280175dex11.htm">Underwriting Agreement, dated August&#160;15, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley&#160;&amp; Co. LLC, Credit Suisse Securities (USA) LLC and Deutsche Bank Securities Inc., as representatives of the several underwriters named therein. </a></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/318154/000119312514209848/d732359dex41.htm">Indenture, dated as of May&#160;22, 2014, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed on May&#160;22, 2014). </a></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d280175dex42.htm">Officer&#8217;s Certificate of the Company, dated as of August&#160;18, 2022, including forms of the Company&#8217;s 4.050% Senior Notes due 2029, 4.200% Senior Notes due 2033 and 4.875% Senior Notes due 2053. </a></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d280175dex51.htm">Opinion of Latham&#160;&amp; Watkins LLP, dated August&#160;18, 2022. </a></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.1</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d280175dex51.htm">Consent of Latham&#160;&amp; Watkins LLP (included in Exhibit 5.1). </a></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">104</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap">AMGEN INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: August&#160;18, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Justin G. Claeys</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">&#160;&#160;Justin G. Claeys</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">&#160;&#160;Vice President, Finance and Treasurer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d280175dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMGEN INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">$1,250,000,000
4.050% SENIOR NOTES DUE 2029 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">$750,000,000 4.200% SENIOR NOTES DUE 2033 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">$1,000,000,000 4.875% SENIOR NOTES DUE 2053 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><U>Underwriting Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right">August 15, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">BofA Securities, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Credit Suisse Securities (USA)
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Deutsche Bank Securities Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">As
representatives of the several Underwriters </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">named in Schedule I hereto </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">c/o BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">One Bryant Park </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">New York, NY 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">c/o Morgan Stanley&nbsp;&amp; Co. LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">1585 Broadway, 29<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">New York, NY 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">c/o Credit Suisse Securities (USA) LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Eleven Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">New York, NY 10010 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">c/o Deutsche Bank Securities Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">1 Columbus Circle </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">New York, NY 10019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Dear Sirs and Mesdames: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Amgen Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), proposes, subject to the terms and conditions stated herein, to issue and sell to the
Underwriters named in Schedule I hereto (the &#147;<U>Underwriters</U>&#148;) an aggregate of $1,250,000,000 principal amount of its 4.050% Senior Notes due 2029 (the &#147;<U>2029 Notes</U>&#148;), $750,000,000 principal amount of its 4.200% Senior
Notes due 2033 (the &#147;<U>2033 Notes</U>&#148;) and $1,000,000,000 principal amount of its 4.875% Senior Notes due 2053 (the &#147;<U>2053 Notes</U>,&#148; and together with the 2029 Notes and the 2033 Notes, the &#147;<U>Securities</U>&#148;) to
be issued pursuant to the provisions of an Indenture dated as of May&nbsp;22, 2014 (the &#147;<U>Indenture</U>&#148;), between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the &#147;<U>Trustee</U>&#148;). BofA
Securities, Inc., Morgan Stanley&nbsp;&amp; Co. LLC, Credit Suisse </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Securities (USA) LLC and Deutsche Bank Securities Inc. have agreed to act as representatives of the Underwriters (the &#147;<U>Representatives</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. (a)&nbsp;The Company represents and warrants to, and agrees with, you that
as of the date hereof and as of the Closing Date: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:12pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;An &#147;automatic shelf registration statement&#148; as
defined under Rule 405 under the Securities Act of 1933, as amended (the &#147;<U>Act</U>&#148;) on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-236351)</FONT> in respect of the Securities has
been filed with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) not earlier than three years prior to the date hereof; such registration statement, and any post-effective amendment thereto, became effective on filing; and
no stop order suspending the effectiveness of such registration statement or any part thereof has been issued and no proceeding for that purpose has been initiated or, to the Company&#146;s knowledge, threatened by the Commission, and no notice of
objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act has been received by the Company (the base prospectus filed as part of such registration
statement, in the form in which it has most recently been filed with the Commission on or prior to the date of this Agreement, is hereinafter called the &#147;<U>Basic Prospectus</U>&#148;; any preliminary prospectus (including any preliminary
prospectus supplement) relating to the Securities filed with the Commission pursuant to Rule 424(b) under the Act is hereinafter called a &#147;<U>Preliminary Prospectus</U>&#148;; the various parts of such registration statement, including all
exhibits thereto but excluding Form <FONT STYLE="white-space:nowrap">T-1</FONT> and including any prospectus supplement relating to the Securities that is filed with the Commission and deemed by virtue of Rule 430B to be part of such registration
statement, each as amended at the time such part of the registration statement became effective, are hereinafter collectively called the &#147;<U>Registration Statement</U>&#148;; the Basic Prospectus, as amended and supplemented immediately prior
to the Applicable Time (as defined in Section&nbsp;1(a)(iii) hereof), is hereinafter called the &#147;<U>Pricing Prospectus</U>&#148;; the form of the final prospectus relating to the Securities filed with the Commission pursuant to Rule 424(b)
under the Act in accordance with Section&nbsp;7(a) hereof is hereinafter called the &#147;<U>Prospectus</U>&#148;; any reference herein to the Basic Prospectus, the Pricing Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to
refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Act, as of the date of such prospectus; any reference to any amendment or supplement to the Basic
Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any post-effective amendment to the Registration Statement, any prospectus supplement relating to the Securities filed with the Commission pursuant to
Rule 424(b) under the Act and any documents filed under the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;), and incorporated therein, in each case after the date of the Basic Prospectus, such Preliminary
Prospectus, or the Prospectus, as the case may be; any reference to any amendment to the Registration Statement shall be deemed to refer to and include any annual report of the Company filed pursuant to Section&nbsp;13(a) or 15(d) of the Exchange
Act after the effective date of the Registration Statement that is incorporated by reference in the Registration Statement; and any &#147;issuer free writing prospectus&#148; as defined in Rule 433 under the Act relating to the Securities is
hereinafter called an &#147;<U>Issuer Free Writing Prospectus</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;No order preventing or suspending
the use of any Preliminary Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission, and each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Preliminary Prospectus, at the time of filing thereof, conformed in all material respects to the requirements of the Act and the Trust Indenture Act of 1939, as amended (the &#147;<U>Trust
Indenture Act</U>&#148;) and the rules and regulations of the Commission thereunder, and did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading; <I>provided, however,</I> that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with
information furnished in writing to the Company by an Underwriter through the Representatives expressly for use therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;For the purposes of this Agreement, the &#147;<U>Applicable Time</U>&#148; is 5:25 p.m., New York City time, on
the date of this Agreement; the Pricing Prospectus as supplemented by the final term sheets prepared and filed pursuant to Section&nbsp;7(a) hereof, taken together (collectively, the &#147;<U>Pricing Disclosure Package</U>&#148;) as of the
Applicable Time, did not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and each
Issuer Free Writing Prospectus listed on Schedule II(a) hereto does not conflict with the information contained in the Registration Statement, the Pricing Prospectus or the Prospectus and each such Issuer Free Writing Prospectus, as supplemented by
and taken together with the Pricing Disclosure Package as of the Applicable Time, did not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; <I>provided, however,</I> that this representation and warranty shall not apply to statements or omissions made in an Issuer Free Writing Prospectus in reliance upon and in conformity with
information furnished in writing to the Company by an Underwriter through the Representatives expressly for use therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;The documents incorporated by reference in the Registration Statement, when they became effective or were filed
with the Commission, as the case may be, conformed in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and none of such documents contained an untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading; any further documents so filed and incorporated by reference in the Registration Statement or
any further amendment or supplement thereto, when such documents become effective or are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the
rules and regulations of the Commission thereunder and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and no such
documents were filed with the Commission since the Commission&#146;s close of business on the business day immediately prior to the date of this Agreement and prior to the execution of this Agreement, except as set forth on Schedule II(b) hereto;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;The Registration Statement conforms, and the Prospectus and any further amendments or supplements to the
Registration Statement and the Prospectus will conform, in all material respects to the requirements of the Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder; and the Registration Statement does not
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
and will not, as of the applicable effective date as to each part of the Registration Statement, contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading; and the Prospectus and any Preliminary Prospectus will not, as of the applicable filing date and any amendment or supplement thereto, include any untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided</I>, <I>however</I>, that this representation and warranty
shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by an Underwriter through the Representatives expressly for use therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;Ernst&nbsp;&amp; Young LLP, which has audited the consolidated financial statements of the Company and its
consolidated subsidiaries incorporated by reference in the Registration Statement, are independent registered public accountants with respect to the Company and its subsidiaries within the meaning of Regulation
<FONT STYLE="white-space:nowrap">S-X</FONT> under the Act and the rules and regulations thereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;The
consolidated financial statements included in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, and the Company&#146;s Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarterly periods ended March&nbsp;31, 2022 and June&nbsp;30, 2022, which are incorporated by reference in the Pricing Prospectus and the Prospectus, present fairly, in all material respects, the
consolidated financial position of the Company and its subsidiaries at December&nbsp;31, 2021 and 2020 and March&nbsp;31, 2022 and June&nbsp;30, 2022, and the consolidated statements of operations and cash flows of the Company and its subsidiaries
for each of the three years in the period ended December&nbsp;31, 2021 and for the three month period ended March&nbsp;31, 2022 and for the six month period ended June&nbsp;30, 2022 are in conformity with accounting principles generally accepted in
the United States (&#147;<U>GAAP</U>&#148;) and the applicable accounting requirements of the Exchange Act and the related rules and regulations adopted by the SEC. The related financial statement schedule, when considered in relation to the basic
consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein for each of the three years in the period ended December&nbsp;31, 2021; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;Since the date as of which information is given in the Pricing Prospectus, except as otherwise stated therein,
(A)&nbsp;there has been no material adverse change in the financial condition or in the earnings of the Company and its subsidiaries considered as one enterprise, (B)&nbsp;there have been no transactions entered into by the Company or any of its
subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries considered as one enterprise, and (C)&nbsp;there has been no dividend or distribution of any kind declared, paid
or made by the Company on any class of its capital stock not described in the Pricing Prospectus; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each subsidiary of the Company listed in Schedule III hereto (such subsidiaries, collectively, the &#147;<U>Significant Subsidiaries</U>&#148;), has been duly incorporated or organized and is validly existing in good standing under the
laws of the jurisdiction in which it is incorporated, chartered or organized with the corporate power and authority to own or lease, as the case may be, and to operate its properties and conduct its business as described in the Pricing Prospectus
and Prospectus and is duly qualified to do </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
business as a foreign corporation or organization and is in good standing under the laws of each jurisdiction which requires such qualification, except, in each case, where the failure so to
qualify or to be in good standing would not have a material adverse effect on the financial condition of the Company and its subsidiaries, considered as one enterprise (a &#147;<U>Material Adverse Effect</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;All the issued and outstanding shares of capital stock of the Significant Subsidiaries have been duly and validly
authorized and issued and are fully paid and nonassessable, and, except as may be otherwise set forth in the Pricing Prospectus and Prospectus, all outstanding shares of capital stock of the Significant Subsidiaries are owned by the Company either
directly or through a wholly-owned subsidiary free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity; none of the outstanding shares of capital stock of the Significant Subsidiaries was issued in violation of
the preemptive or similar rights of any securityholder of any Significant Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;None of the
Significant Subsidiaries is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution on such subsidiary&#146;s capital stock, from repaying to the Company any loans or advances to
such subsidiary from the Company or from transferring any of such subsidiary&#146;s property or assets to the Company or any other subsidiary of the Company, except as may be described in or contemplated by the Pricing Prospectus and Prospectus and
except as would not result in a Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;The consolidated capitalization of the Company as
of June&nbsp;30, 2022 is as set forth in the Pricing Prospectus and Prospectus in the column entitled &#147;Actual&#148; under the caption &#147;Capitalization.&#148; The outstanding shares of capital stock of the Company have been duly and validly
authorized and issued and are fully paid and nonassessable; none of the outstanding shares of capital stock of the Company was issued in violation of the preemptive or similar rights of any security holder of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;This Agreement has been duly authorized, executed and delivered by the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;The Indenture has been duly authorized, executed and delivered by the Company and, assuming the due
authorization, execution and delivery of the Indenture by the Trustee, is a valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except (A)&nbsp;to the extent that a waiver of rights under any
usury laws may be unenforceable and as the enforceability thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, moratorium or other similar laws now or hereafter in effect relating to or affecting the enforcement of
creditors&#146; rights and remedies generally and (B)&nbsp;as rights of acceleration and the availability of equitable remedies may be limited by equitable principles of general applicability, whether or not enforcement is sought at law or in
equity; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xv)&nbsp;&nbsp;&nbsp;&nbsp;The Securities have been duly authorized by the Company, and, on the Closing Date, the Securities
will have been duly executed by the Company and, when authenticated, issued and delivered in the manner provided for in the Indenture and delivered against payment of the purchase price therefore as provided in this Agreement, will be the valid
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
and binding obligations of the Company, enforceable against the Company in accordance with their terms, except (A)&nbsp;to the extent that a waiver of rights under any usury laws may be
unenforceable and as the enforceability thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, moratorium or other similar laws now or hereafter in effect relating to or affecting the enforcement of creditors&#146; rights and
remedies generally and (B)&nbsp;as rights of acceleration and the availability of equitable remedies may be limited by equitable principles of general applicability, whether or not enforcement is sought at law or in equity. At the Closing Date, the
Securities will be in the form contemplated by, and will be entitled to the benefits of, the Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;The
Securities and the Indenture will conform in all material respects to the respective statements relating thereto contained in the Pricing Disclosure Package and Prospectus; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its Significant Subsidiaries is in violation of its charter or <FONT
STYLE="white-space:nowrap">by-laws</FONT> or in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or
other agreement or instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound, or to which any of the property or assets of the Company or any of its subsidiaries is subject, except for such
defaults that would not result in a Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;The execution, delivery and performance by
the Company of its obligations under this Agreement, the Indenture and the Securities will not contravene any provision of (A)&nbsp;the Amended and Restated Certificate of Incorporation, or Amended and Restated Bylaws of the Company, (B)&nbsp;any
agreement or other instrument binding upon the Company or its business or assets that is material to the financial condition of the Company and its subsidiaries, considered as one enterprise, (C)&nbsp;applicable law, or (D)&nbsp;any judgment, order,
decree of any governmental body, agency or court having jurisdiction over the Company or its business or assets; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xix)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in the Pricing Prospectus and Prospectus, there is no action, suit, proceeding, inquiry or
investigation before or brought by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries which might reasonably be
expected to result in a Material Adverse Effect, or which might reasonably be expected to materially and adversely affect the properties or assets of the Company or any of its subsidiaries or the consummation of the transactions contemplated by this
Agreement or the performance by the Company of its obligations hereunder. The aggregate of all pending legal or governmental proceedings to which the Company or any of its subsidiaries is a party or of which any of their respective property or
assets is the subject which are not described in the Pricing Prospectus and Prospectus, including ordinary routine litigation incidental to the business, could not reasonably be expected to result in a Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xx)&nbsp;&nbsp;&nbsp;&nbsp;Except as described in the Pricing Prospectus and Prospectus, the Company and its Significant Subsidiaries own or
possess, or can acquire on reasonable terms, adequate patents, patent rights, licenses, inventions, copyrights, <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks and trade names (collectively, &#147;<U>Intellectual
Property</U>&#148;) which in each case are material to the financial condition of the Company and its subsidiaries, considered as one enterprise, and neither the Company nor any of its Significant Subsidiaries has received any notice of any
infringement of or conflict with asserted rights of others with respect to any Intellectual Property, which infringement or conflict, singly or in the aggregate, could reasonably be expected to result in a Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;No consent, approval, authorization or order of or qualification with any governmental body or agency is
required for the performance by the Company of its obligations under this Agreement, the Indenture or in connection with the offering, issuance and sale of the Securities, except (A)&nbsp;such as have been already obtained or will have been obtained
prior to the Closing Date, or (B)&nbsp;as may be required under the rules and regulations promulgated under the Act and the Trust Indenture Act and the rules and regulations thereunder, in each case with respect to transactions contemplated by the
Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;The Company has all necessary consents, authorizations, approvals, orders, certificates and
permits of and from (collectively, &#147;<U>Governmental Permits</U>&#148;), and has made all declarations and filings with, all federal, state, local and other governmental authorities, all self-regulatory organizations and all courts and other
tribunals, to own, lease, license and use its properties and assets and to conduct its business in the manner described in the Pricing Prospectus and Prospectus, except to the extent that the failure to obtain or file would not have a Material
Adverse Effect; and the Company has not received any notice of proceedings relating to the revocation or modification of any such Governmental Permits which, singly or in the aggregate, could reasonably be expected to result in a Material Adverse
Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp;Except as described in the Pricing Prospectus and Prospectus and except as would not, singly or
in the aggregate, result in a Material Adverse Effect, (A)&nbsp;neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or
any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient air,
surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous
substances, petroleum or petroleum products (collectively, &#147;<U>Hazardous Materials</U>&#148;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively,
&#147;<U>Environmental Laws</U>&#148;), (B) the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance with their requirements, (C)&nbsp;there are no
pending or threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigations or proceedings relating to any Environmental Law against the Company or any of
its subsidiaries and (D)&nbsp;there are no events or circumstances that might reasonably be expected to form the basis of an order for <FONT STYLE="white-space:nowrap">clean-up</FONT> or remediation, or an action, suit or proceeding by any private
party or governmental body or agency, against or affecting the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxiv)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor any of its subsidiaries is in
violation of any Federal or state law or regulation relating to occupational safety and health or to the storage, handling and transportation of hazardous or toxic materials, the Company and each of its subsidiaries have received all permits,
licenses or other approvals required of them under applicable Federal and state occupational safety and health laws and Environmental Laws and regulations to conduct their respective businesses, and the Company and each such subsidiary is in
compliance with all terms and conditions of any such permit, license or approval, except any such violation of law or regulation, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of
such permits, licenses or approvals that would not, singly or in the aggregate, result in a Material Adverse Effect, except as described in or contemplated by the Pricing Prospectus and Prospectus; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxv)&nbsp;&nbsp;&nbsp;&nbsp;The Company and its subsidiaries, taken as a whole, maintain a system of internal accounting controls sufficient
to provide reasonable assurances that (A)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorization; (B)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in
conformity with GAAP and to maintain accountability for assets; (C)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; and (D)&nbsp;the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxvi)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not, and after giving effect to the offering and sale of the Securities and the application of
the proceeds thereof as described in the Pricing Prospectus and Prospectus, will not be an &#147;investment company,&#148; or an entity &#147;controlled&#148; by an investment company, as such terms are defined in the Investment Company Act of 1940,
as amended; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxvii)&nbsp;&nbsp;&nbsp;&nbsp;The Company and each of its subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are reasonable and consistent with sound business practice; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxviii)&nbsp;&nbsp;&nbsp;&nbsp; To the knowledge of the Company, the conduct of the business of the Company and of its subsidiaries,
including, as conducted by any of the directors, officers, employees, agents or representatives of the Company or any of its subsidiaries, has been in material compliance with applicable anti-bribery and corruption laws, including but not limited to
the Foreign Corrupt Practices Act of 1977, as amended (the &#147;<U>FCPA</U>&#148;); and the Company and its subsidiaries have instituted and maintained policies and procedures designed to promote and achieve compliance with such applicable
anti-bribery and corruption laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxix)&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;(i) At the time of filing the Registration Statement,
(ii)&nbsp;at the time of the most recent amendment thereto, if any, for the purposes of complying with Section&nbsp;10(a)(3) of the Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section&nbsp;13 or
15(d) of the Exchange Act or form of prospectus), and (iii)&nbsp;at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Act) made any offer relating to the Securities in
reliance on the exemption of Rule 163 under the Act, the Company was a &#147;well-known seasoned issuer&#148; as defined in Rule 405 under the Act; and (B)&nbsp;at the earliest time after the filing of the Registration
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Statement that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Act) of the Securities, the Company was not an &#147;ineligible
issuer&#148; as defined in Rule 405 under the Act; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(xxx)&nbsp;&nbsp;&nbsp;&nbsp;The Company is subject to the reporting requirements
of Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Officer&#146;s Certificate</U>. Any
certificate signed by any officer of the Company and delivered to the Underwriters or counsel for the Underwriters in connection with the issuance of the Securities shall be deemed a representation and warranty by the Company, as to matters covered
thereby, to the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreements to Sell and Purchase</U>. (a)&nbsp;The Company hereby agrees to
sell to the several Underwriters, and each Underwriter, upon the basis of the representations and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and not jointly, to purchase from the Company the
respective principal amount of Securities set forth opposite its name in Schedule I hereto and the Company and the Underwriters agree that the Company shall receive 99.467% of the aggregate principal amount of the 2029 Notes, 99.548% of the
aggregate principal amount of the 2033 Notes and 99.107% of the aggregate principal amount of the 2053 Notes, plus accrued interest, in each case, if any, from the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby agrees that, without the prior written consent of the Representatives on behalf of the
Underwriters, it will not, during the period beginning on the date of this Agreement and continuing to and including the Closing Date, offer, sell, contract to sell or otherwise dispose of any debt of the Company or warrants to purchase debt of the
Company substantially similar to the Securities (other than the sale of the Securities under this Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Terms of Offering</U>. Upon the authorization by you of the release of the Securities, the several Underwriters
propose to offer the Securities for sale upon the terms and conditions set forth in the Pricing Disclosure Package and Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase and Delivery</U>. (a)&nbsp;Payment for the Securities shall be made to the Company in Federal or other
funds immediately available in New York City against delivery of such Securities for the respective accounts of the several Underwriters at 10:00 a.m., New York City time, on August 18, 2022, or at such other time on the same or such other date as
shall be agreed by the parties. The time and date of such payment are hereinafter referred to as the &#147;<U>Closing Date</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Certificates for the Securities, if any, shall be in global form and registered in the name of Cede&nbsp;&amp;
Co., as nominee of the Depository Trust Company. The certificates evidencing the Securities shall be delivered to the Trustee on the Closing Date for the respective accounts of the several Underwriters, with any transfer taxes payable in connection
with the transfer of the Securities to the Underwriters duly paid, against payment of the purchase price therefor plus accrued interest, if any, to the date of payment and delivery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Free Writing Prospectuses</U>. (a)&nbsp;(i)&nbsp;The Company represents and agrees that, other than the final
term sheets prepared and filed pursuant to Section&nbsp;7(a) hereof, without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
the prior consent of the Representatives, it has not made and will not make any offer relating to the Securities that would constitute a &#147;free writing prospectus&#148; as defined in Rule 405
under the Act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:12pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;each Underwriter represents and agrees that, without the prior consent of the Company and the
Representatives, other than (A)&nbsp;one or more customary Bloomberg screens to offer the Securities or convey the pricing terms thereof and (B)&nbsp;one or more term sheets relating to the Securities containing customary information and conveyed to
purchasers of Securities, it has not made and will not make any offer relating to the Securities that would constitute a free writing prospectus required to be filed with the Commission; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:12pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;any such free writing prospectus, the use of which has been consented to by the Company and the Representatives
(other than the final term sheet prepared and filed pursuant to Section&nbsp;7(a) hereof), is listed on Schedule II(a) hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has complied and will comply with the requirements of Rule 433 under the Act applicable to any Issuer
Free Writing Prospectus, including timely filing with the Commission or retention where required and legending. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company agrees that if at any time following issuance of an Issuer Free Writing Prospectus any event occurred
or occurs as a result of which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the Pricing Prospectus or the Prospectus or would include an untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not misleading, the Company will give prompt notice thereof to the Representatives, and if requested by the Representatives, will
prepare and furnish without charge to each Underwriter an Issuer Free Writing Prospectus or other document which will correct such conflict, statement or omission; <I>provided, however,</I> that this representation and warranty shall not apply to
any statements or omissions in an Issuer Free Writing Prospectus made in reliance upon and in conformity with information furnished in writing to the Company by an Underwriter through the Representatives expressly for use therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to the Underwriters&#146; Obligations</U>. The several obligations of the Underwriters to purchase
and pay for the Securities on the Closing Date are subject to the following conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Prospectus shall
have been filed with the Commission pursuant to Rule 424(b) under the Act within the applicable time period prescribed for such filing by the rules and regulations under the Act and in accordance with Section&nbsp;7(a) hereof; the final term sheet
contemplated by Section&nbsp;7(a) hereof, and any other material required to be filed by the Company pursuant to Rule 433(d) under the Act, shall have been filed with the Commission within the applicable time periods prescribed for such filings by
Rule 433; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission and no notice of objection of
the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act shall have been received; no stop order suspending or preventing the use of the Prospectus or any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
Issuer Free Writing Prospectus shall have been initiated or threatened by the Commission; and all requests for additional information on the part of the Commission shall have been complied with
to your reasonable satisfaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subsequent to the execution and delivery of this Agreement and prior to the
Closing Date: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:12pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;there shall not have occurred any downgrading, nor shall any notice have been given of any
intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded of any of the Company&#146;s securities by any &#147;nationally recognized statistical
rating organization,&#148; as such term is defined for purposes of Section&nbsp;3(a)(62) of the Exchange Act; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:12pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;there shall not have been, since the date of this Agreement or since the respective dates as of which information
is given in the Pricing Prospectus and Prospectus, any material adverse change in the financial condition or in the earnings of the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Underwriters shall have received on the Closing Date, a certificate, dated as of the date of the Closing Date
and signed by the chief executive officer, the chief financial officer or the treasurer of the Company, to the effect set forth in Section&nbsp;6(b)(i) and to the effect that (i)&nbsp;the representations and warranties of the Company contained in
this Agreement are true and correct in all material respects as of the Closing Date and (ii)&nbsp;the Company has complied in all material respects with all of the agreements and satisfied in all material respects all of the conditions on its part
to be performed or satisfied hereunder on or before the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">The officer signing and delivering such certificate may rely upon
the best of his or her knowledge as to proceedings threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Underwriters shall have received on the
Closing Date an opinion or opinions and a negative assurances letter of Latham&nbsp;&amp; Watkins LLP, outside counsel for the Company, dated the date of the Closing Date, in the form previously agreed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Underwriters shall have received on the Closing Date an opinion of the Company&#146;s general counsel or any
associate general counsel, dated the date of the Closing Date, in the form previously agreed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The
Underwriters shall have received on the Closing Date, an opinion and a negative assurances letter of Shearman&nbsp;&amp; Sterling LLP, counsel for the Underwriters, dated the date of the Closing Date, in the form previously agreed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Underwriters and the board of directors of the Company shall have received on the date hereof, on the
effective date of any post-effective amendment to the Registration Statement filed subsequent to the date of this Agreement and also on the Closing Date, a letter, dated the respective dates of delivery thereof, in form and substance reasonably
satisfactory to the Underwriters, from Ernst&nbsp;&amp; Young LLP, independent registered public accountants, containing statements and information of the type ordinarily included in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information contained in or incorporated by reference into the
Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants of the Company</U>. In further consideration of the agreements of the
Underwriters contained in this Agreement, the Company covenants and agrees with each Underwriter as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;To prepare the Prospectus in a form approved by you and to file such Prospectus pursuant to Rule 424(b) under the
Act not later than the Commission&#146;s close of business on the second business day following the date of this Agreement; to make no further amendment or any supplement to the Registration Statement, the Basic Prospectus or the Prospectus prior to
the Closing Date which shall be disapproved by you promptly after reasonable notice thereof; to advise you, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or becomes effective
or any amendment or supplement to the Prospectus has been filed and to furnish you with copies thereof; to prepare final term sheets, containing solely a description of the Securities, in a form approved by you and to file such term sheets pursuant
to Rule 433(d) under the Act within the time required by such Rule; to file promptly all other material required to be filed by the Company with the Commission pursuant to Rule 433(d) under the Act; to file promptly all reports and any definitive
proxy or information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus
(or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is required in connection with the offering or sale of the Securities; to advise you, promptly after it receives notice thereof, of the issuance by the Commission of any stop
order or of any order preventing or suspending the use of any Preliminary Prospectus or other prospectus in respect of the Securities, of any notice of objection of the Commission to the use of the Registration Statement or any post-effective
amendment thereto pursuant to Rule 401(g)(2) under the Act, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any request
by the Commission for the amending or supplementing of the Registration Statement or the Prospectus or for additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of any
Preliminary Prospectus or other prospectus or suspending any such qualification, to promptly use its commercially reasonable efforts to obtain the withdrawal of such order; and in the event of any such issuance of a notice of objection, promptly to
take such steps including, without limitation, amending the Registration Statement or filing a new registration statement, at its own expense, as may be necessary to permit offers and sales of the Securities by the Underwriters (references herein to
the Registration Statement shall include any such amendment or new registration statement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If required by
Rule 430B(h) under the Act, to prepare a form of prospectus in a form approved by you and to file such form of prospectus pursuant to Rule 424(b) under the Act not later than may be required by Rule 424(b) under the Act; and to make no further
amendment or supplement to such form of prospectus which shall be disapproved by you promptly after reasonable notice thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;If by the third anniversary (the &#147;<U>Renewal
Deadline</U>&#148;) of the initial effective date of the Registration Statement, any of the Securities remain unsold by the Underwriters, the Company will file, if it has not already done so and is eligible to do so, a new automatic shelf
registration statement relating to the Securities, in a form reasonably satisfactory to you. If at the Renewal Deadline the Company is no longer eligible to file an automatic shelf registration statement, the Company will, if it has not already done
so, file a new shelf registration statement relating to the Securities, in a form reasonably satisfactory to you and will use its commercially reasonable efforts to cause such registration statement to become effective within 180 days after the
Renewal Deadline. The Company will take all other action reasonably necessary or appropriate to permit the public offering and sale of the Securities to continue as contemplated in the expired registration statement relating to the Securities.
References herein to the Registration Statement shall include such new automatic shelf registration statement or such new shelf registration statement, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;As soon as practicable following the date of this Agreement and from time to time, to furnish the Underwriters
with written and electronic copies of the Prospectus in New York City in such quantities as you may reasonably request, and, if the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is required at any
time prior to the expiration of nine months after the time of issue of the Prospectus in connection with the offering or sale of the Securities and if at such time any event shall have occurred as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus (or in lieu
thereof, the notice referred to in Rule 173(a) under the Act) is delivered, not misleading, or, if for any other reason it shall be necessary during such same period to amend or supplement the Prospectus or to file under the Exchange Act any
document incorporated by reference in the Prospectus in order to comply with the Act, the Exchange Act or the Trust Indenture Act, to notify you and upon your request to file such document and to prepare and furnish without charge to each
Underwriter and to any dealer in securities as many written and electronic copies as you may from time to time reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or omission or effect such
compliance; and in case any Underwriter is required to deliver a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Act) in connection with sales of any of the Securities at any time nine months or more after the time of
issue of the Prospectus, upon your request but at the expense of such Underwriter, to prepare and deliver to such Underwriter as many written and electronic copies as you may request of an amended or supplemented Prospectus complying with
Section&nbsp;10(a)(3) of the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;To make generally available to its securityholders as soon as practicable,
but in any event not later than sixteen months after the effective date of the Registration Statement (as defined in Rule 158(c) under the Act), an earnings statement of the Company and its subsidiaries (which need not be audited) complying with
Section&nbsp;11(a) of the Act and the rules and regulations of the Commission thereunder (including, at the option of the Company, Rule 158). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;To pay the required Commission filing fees relating to the
Securities within the time required by Rule 456(b)(1) under the Act without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;To endeavor to qualify the Securities for offer and sale under the securities or Blue Sky laws of such
jurisdictions as you shall reasonably request <I>provided, however</I>, that the Company shall not be required to (i)&nbsp;qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise be required to
qualify but for this Section&nbsp;7(g), (ii) file any general consent to service of process, (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not so subject or (iv)&nbsp;make any changes to its certificate of incorporation or
bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is
terminated, to pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i)&nbsp;the fees, disbursements and expenses of the Company&#146;s counsel and the Company&#146;s accountants in
connection with the registration of the Securities and all other fees or expenses of the Company in connection with the preparation, printing, production and filing of the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, any
Issuer Free Writing Prospectus and the Prospectus and any amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers; (ii)&nbsp;all costs and expenses related to the preparation, issuance and
delivery of the Securities to the Underwriters, including any transfer or other taxes payable thereon; (iii)&nbsp;all expenses in connection with the qualification of the Securities for offer and sale under state securities laws as provided in
Section&nbsp;7(g) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection with such qualification and in connection with the preparation of any Blue Sky or legal investment memorandum;
(iv)&nbsp;any fees charged by rating agencies for the rating of the Securities; (v)&nbsp;any filing fees incident to, and any fees and disbursements of counsel for the Underwriters in connection with, any required review by the Financial Industry
Regulatory Authority of the terms of the sale of the Securities; (vi)&nbsp;the costs and charges of the Trustee; and (vii)&nbsp;all other cost and expenses incident to the performance of the obligations of the Company hereunder for which provision
is not otherwise made in this Section. It is understood, however, that except as provided in clauses (iii)&nbsp;and (v) of this Section&nbsp;7(h), and the last paragraph of Section&nbsp;10, the Underwriters will pay all of their costs and expenses,
including fees and disbursements of their counsel, transfer taxes payable on resale of any of the Securities by them and any advertising expenses connected with any offers they may make. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnity and Contribution</U>. (a)&nbsp;The Company will indemnify and hold harmless each Underwriter against
any losses, claims, damages or liabilities, joint or several, to which such Underwriter may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based
upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, any
Issuer Free Writing Prospectus or any &#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) under the Act, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading, and will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
reimburse such Underwriter for any legal or other expenses reasonably incurred by it in connection with investigating or defending any such action or claim as such expenses are incurred;
<I>provided, however</I>, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged
omission made in the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus relating to the Securities, or in
any such amendment or supplement thereto, in reliance upon and in conformity with written information furnished to the Company by such Underwriter expressly for use therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Underwriter will severally and not jointly indemnify and hold harmless the Company against any losses,
claims, damages or liabilities to which the Company may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus,
or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that
such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement
thereto, or any Issuer Free Writing Prospectus relating to the Securities, in reliance upon and in conformity with written information furnished to the Company by such Underwriter expressly for use therein; and will reimburse the Company for any
legal or other expenses reasonably incurred by the Company in connection with investigating or defending any such action or claim as such expenses are incurred. The Company hereby acknowledges that the only information furnished to the Company by
any Underwriter expressly for use in the Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus relating to
the Securities, is the names of the Underwriters on the cover page and back page of the Pricing Prospectus and the Prospectus and, under the caption &#147;Underwriting&#148; in the Pricing Prospectus and the Prospectus: (i)&nbsp;the second and third
sentences of the third paragraph of text, concerning the terms of the offering by the Underwriters, (ii)&nbsp;the third sentence of the fourth paragraph of text concerning market making by the Underwriters, and (iii)&nbsp;the fifth, sixth and
seventh paragraphs of text, concerning short sales, stabilizing transactions and purchases to cover positions created by short sales by the Underwriters and penalty bids. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;As promptly as reasonably practical after receipt by an indemnified party under paragraph (a)&nbsp;or (b) above of
notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the indemnifying party in writing of the commencement thereof; but the
omission so to notify the indemnifying party shall not relieve it of its obligations (i)&nbsp;under paragraph (a)&nbsp;or (b), as applicable, of this Section&nbsp;8 unless and only to the extent that the indemnifying party is materially prejudiced
by the failure to notify, or (ii)&nbsp;from any liability which it may have to any indemnified party otherwise than under such applicable subsection. In </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate
therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, and retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and
any others the indemnifying party may designate in such proceeding and shall pay the fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party shall have the right to retain its own counsel, but
the fees and expenses of such counsel shall be at the expense of such indemnified party unless (1)&nbsp;the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or (2)&nbsp;the named parties to any
such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would, in the written opinion of legal counsel to the indemnified party, be
inappropriate due to actual or potential differing interests between them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">It is understood that the indemnifying party shall not, in
respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all
such indemnified parties and that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall be designated in writing by the Representatives or, if none of the Representatives is an indemnified party and is not reasonably
likely to become an indemnified party, by the Underwriters that are indemnified parties, in the case of parties indemnified pursuant to paragraph (a)&nbsp;above, and by the Company, in the case of parties indemnified pursuant to paragraph
(b)&nbsp;above. No indemnifying party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect
of which indemnification or contribution may be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i)&nbsp;includes an unconditional release
of the indemnified party from all liability arising out of such action or claim and (ii)&nbsp;does not include a statement as to, or an admission of, fault, culpability or a failure to act, by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;If the indemnification provided for in this Section&nbsp;8 is unavailable or insufficient to hold harmless an
indemnified party under subsection (a)&nbsp;or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by
such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and each Underwriter on
the other from the offering of the Securities to which such loss, claim, damage or liability (or action in respect thereof) relates. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law, then
each indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and each
Underwriter on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative benefits
received by the Company on the one hand and each Underwriter on the other shall be deemed to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
be in the same proportion as the total net proceeds from the sale of Securities (before deducting expenses) received by the Company bear to the total commissions and discounts received by such
Underwriter in respect thereof. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact required to be
stated therein or necessary in order to make the statements therein not misleading relates to information supplied by the Company on the one hand or by any Underwriter on the other and the parties&#146; relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. The Company and each Underwriter agree that it would not be just and equitable if contribution pursuant to this subsection (d)&nbsp;were determined by pro rata allocation
(even if all Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this subsection (d). The amount paid or payable by an
indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this subsection (d)&nbsp;shall be deemed to include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection (d), an Underwriter shall not be required to contribute any amount in excess of the amount by which the total price at
which the Securities that were offered and sold to the public through such Underwriter exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or
alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The obligations of
each of the Underwriters under this subsection (d)&nbsp;to contribute are several in proportion to the respective purchases made by or through each such Underwriter to which such loss, claim, damage or liability (or action in respect thereof)
relates and are not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The obligations of the Company under this Section&nbsp;8 shall be in addition to
any liability which the Company may otherwise have and shall extend, upon the same terms and conditions, to each officer, director, employee, agent or affiliate of any Underwriter and to each person, if any, who controls any Underwriter within the
meaning of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act; and the obligations of each Underwriter under this Section&nbsp;8 shall be in addition to any liability which such Underwriter may otherwise have and shall extend, upon
the same terms and conditions, to each officer and director of the Company and to each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement shall be subject to termination in the Underwriters&#146; absolute discretion,
by written notice to the Company, if (a)&nbsp;after the execution and delivery of this Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on or by, as the case may be, any of the New
York Stock Exchange, NYSE MKT or the Nasdaq Stock Market, (ii)&nbsp;trading of any securities of the Company shall have been suspended on any exchange or in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, (iii)&nbsp;a general moratorium on commercial banking activities in New York shall have been declared by either Federal or New York State
authorities, or (iv)&nbsp;there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis that, in the judgment of the Underwriters, is material and adverse and (b)&nbsp;in the case of
any of the events </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
specified in clauses (a)(i) through (iv), such event, singly or together with any other such event, makes it, in the judgment of the Underwriters, impracticable to market the Securities on the
terms and in the manner contemplated in the Pricing Disclosure Package and Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effectiveness;
Defaulting Underwriters</U>. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">If, on
the Closing Date, any one or more of the Underwriters shall fail or refuse to purchase Securities that it or they have agreed to purchase hereunder on such date, and the aggregate principal amount of Securities which such defaulting Underwriter or
Underwriters agreed but failed or refused to purchase is not more than <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of Securities to be purchased on such date, the other Underwriters shall be obligated
severally in the proportions that the principal amount of Securities set forth opposite their respective names in Schedule I bears to the aggregate principal amount of Securities set forth opposite the names of all such <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, or in such other proportions as you may specify, to purchase the Securities which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date;
<I>provided </I>that in no event shall the principal amount of Securities that any Underwriter has agreed to purchase pursuant to this Agreement be increased pursuant to this Section&nbsp;10 by an amount in excess of
<FONT STYLE="white-space:nowrap">one-ninth</FONT> of such principal amount of Securities without the written consent of such Underwriter. If, on the Closing Date any Underwriter or Underwriters shall fail or refuse to purchase Securities which it or
they have agreed to purchase hereunder on such date and the aggregate principal amount of Securities with respect to which such default occurs is more than <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of
Securities to be purchased on such date, and arrangements satisfactory to you and the Company for the purchase of such Securities are not made within 36 hours after such default, this Agreement shall terminate without liability on the part of any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or of the Company. In any such case either you or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required
changes, if any, in the Prospectus or in any other documents or arrangements may be effected. Any action taken under this paragraph shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">If this Agreement shall be terminated by the Underwriters, or any of them, because of any failure or refusal on the part of
the Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable to perform its obligations under this Agreement (except if the Company shall be unable to so perform as a
result of any default by any Underwriter as contemplated above), the Company will reimburse the Underwriters or such Underwriters as have so terminated this Agreement with respect to themselves, severally, for all <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (including the fees and disbursements of their counsel) reasonably incurred by such Underwriters in connection with this Agreement or the offering contemplated hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This Agreement may be executed in any number of counterparts and by the parties in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Applicable Law</U>. This Agreement shall be governed by the
laws of the State of New York, including, without limitation, <FONT STYLE="white-space:nowrap">Section&nbsp;5-1401</FONT> of the New York General Obligations Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. In the event that any one or more of the provisions contained herein, or the application
thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein shall not be affected or impaired
thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Section References</U>. Unless otherwise indicated, references in this Agreement to sections are
to the sections of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the construction hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice</U>. All notices
and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication. Notices to the Underwriters shall be directed to BofA Securities, Inc., 1540
Broadway, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NY8-540-26-02,</FONT></FONT></FONT> New York, NY 10036 (facsimile no.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-901-7881),</FONT></FONT> Attention: High Grade Debt Capital Markets Transaction Management/Legal, to Credit Suisse Securities (USA) LLC, Eleven Madison Avenue, New York, NY
10010-3629 (facsimile <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-325-4296),</FONT></FONT> Attention: IBCM-Legal, to Deutsche Bank Securities Inc., 1 Columbus Circle New York, NY 10019 (facsimile no. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">646-374-1071),</FONT></FONT> Attention: Leverage Debt Capital Markets General Counsel, 19th Floor and to Morgan Stanley&nbsp;&amp; Co. LLC, 1585 Broadway, 29th Floor, New York, NY 10036
(facsimile no. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-507-8999),</FONT></FONT> Attention: Investment Banking Division and with a copy to Shearman&nbsp;&amp; Sterling LLP at 1460 El Camino Real, 2<U><SUP
STYLE="font-size:75%; vertical-align:top">nd</SUP></U> floor, Menlo Park, California 94025 (facsimile no. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">650-838-5140),</FONT></FONT> Attention: Christopher M. Forrester; notices to
the Company shall be directed to it at One Amgen Center Drive, Thousand Oaks, California 91320-1799 (facsimile no. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-499-8011),</FONT></FONT> Attention: Corporate Secretary, with a
copy to Latham&nbsp;&amp; Watkins LLP, 650 Town Center Drive, 20<U><SUP STYLE="font-size:75%; vertical-align:top">th</SUP></U> Floor, Costa Mesa, CA 92626 (facsimile no.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">714-755-8290),</FONT></FONT> Attention: Charles K. Ruck and Latham&nbsp;&amp; Watkins LLP, 1271 Avenue of the Americas, New York, New York 10020 (facsimile no. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-751-4864),</FONT></FONT> Attention: Gregory P. Rodgers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">In accordance
with the requirements of the USA Patriot Act (Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their
respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Advisory or Fiduciary Relationship</U>. The Company acknowledges and agrees that (a)&nbsp;the purchase and
sale of the Securities pursuant to this Agreement, including the determination of the offering price of the Securities and any related discounts and commissions, is an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction
between the Company, on the one hand, and the several Underwriters, on the other hand, (b)&nbsp;in connection with the offering contemplated hereby and the process leading to such transaction each Underwriter is and has been acting solely as a
principal and is not the agent or fiduciary of the Company, or its stockholders, creditors, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
employees or any other party, (c)&nbsp;no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby
or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) and no Underwriter has any obligation to the Company with respect to the offering contemplated hereby except
the obligations expressly set forth in this Agreement, (d)&nbsp;the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of each of the Company, and (e)&nbsp;the
Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby and the Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Integration</U>. This Agreement supersedes all prior agreements and understandings (whether written or
oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Jury Trial</U>. The Company and each of the Underwriters hereby irrevocably waives, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Recognition of the U.S. Special Resolution Regimes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special
Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if
this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes
subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under
the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">As
used in this Section&nbsp;20, &#147;<U>BHC Act Affiliate</U>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k); &#147;<U>Covered Entity</U>&#148; means any of
the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&nbsp;252.82(b), (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12
C.F.R. &#167;&nbsp;47.3(b) or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&nbsp;382.2(b); &#147;<U>Default Right</U>&#148; has the meaning assigned to that term in, and shall
be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and &#147;<U>U.S. Special Resolution Regime</U>&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"><B>AMGEN INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;&nbsp;/s/ Justin G. Claeys</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;Name: Justin G. Claeys</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;Title:&nbsp;&nbsp;&nbsp;Vice&nbsp;President,&nbsp;Finance&nbsp;and&nbsp;Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Underwriting Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Accepted as of the date hereof: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"><B>BOFA SECURITIES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">/s/ Douglas Muller</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Name: Douglas Muller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"><B>CREDIT SUISSE SECURITIES (USA) LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">/s/ Christopher Murphy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Name: Christopher Murphy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"><B>DEUTSCHE BANK SECURITIES INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">/s/ John C. McCabe</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Name: John C. McCabe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">/s/ Kevin Prior</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Name: Kevin Prior</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Title: Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"><B>MORGAN STANLEY&nbsp;&amp; CO. LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">/s/ Keren Ehrenfeld</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Name: Keren Ehrenfeld</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Title: Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Acting severally on behalf of themselves and the several Underwriters named in Schedule I hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Underwriting Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>UNDERWRITER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>PRINCIPAL<BR>AMOUNT OF<BR>2029 NOTES TO<BR>BE&nbsp;PURCHASED</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>PRINCIPAL<BR>AMOUNT OF<BR>2033&nbsp;NOTES&nbsp;TO<BR>BE&nbsp;PURCHASED</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>PRINCIPAL<BR>AMOUNT OF<BR>2053 NOTES TO<BR>BE&nbsp;PURCHASED</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$187,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$112,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$150,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$187,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$112,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$150,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Credit Suisse Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$168,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$101,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$135,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deutsche Bank Securities Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$168,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$101,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$135,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$93,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$56,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$75,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$93,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$56,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$75,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$93,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$56,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$75,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$93,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$56,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$75,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$12,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$7,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$10,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC Securities (USA) Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$12,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$7,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$10,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG Securities Americas Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$12,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$7,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$10,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piper Sandler&nbsp;&amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$12,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$7,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$10,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$12,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$7,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$10,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$12,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$7,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$10,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$12,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$7,500,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$10,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AmeriVet Securities Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$18,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$11,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$15,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Blaylock Van, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$18,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$11,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$15,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MFR Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$18,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$11,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$15,000,000</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Penserra Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$18,750,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$11,250,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$15,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$1,250,000,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$750,000,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$1,000,000,000</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Issuer Free Writing Prospectuses not included in the Pricing Disclosure Package: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:12pt; font-family:Times New Roman">None. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; Additional Documents Incorporated by Reference: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:12pt; font-family:Times New Roman">None. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNIFICANT SUBSIDIARIES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#000000">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#000000" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Subsidiary</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Jurisdiction of
Incorporation/Formation</FONT></B></FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen (Europe) GmbH</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Switzerland</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Canada Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Canada</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Fremont Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Global Finance B.V.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Netherlands</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen GmbH Germany</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Germany</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Ila&ccedil; Ticaret Limited &#350;irketi</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Turkey</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen <FONT STYLE="white-space:nowrap">K-A,</FONT> Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Manufacturing, Limited</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Bermuda</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Research (Munich) GmbH</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Germany</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Rockville, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen S.A.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Spain</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen S.A.S.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">France</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen S.R.L.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Italy</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen SF, LLC</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Singapore Manufacturing Pte. Ltd.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Singapore</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Technology (Ireland) Unlimited Company</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Ireland</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Technology, Limited</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Bermuda</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen USA Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Amgen Worldwide Holdings B.V.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Netherlands</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">BioVex, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">deCODE Genetics ehf</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Iceland</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Five Prime Therapeutics Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Ilypsa, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Immunex Corporation</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Washington</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Immunex Rhode Island Corporation</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Gensenta &#304;la&ccedil; Sanayi ve Ticaret Anonim &#350;irketi</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Turkey</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">KAI Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Onyx Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Onyx Therapeutics, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Saga Investments Co&ouml;peratief U.A.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Netherlands</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">TeneoBio, Inc.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Delaware</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d280175dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OFFICER&#146;S CERTIFICATE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMGEN INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated as of August&nbsp;18, 2022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The undersigned officer of the Company certifies, pursuant to resolutions duly adopted by the Board of Directors at a meeting
duly held on August&nbsp;3, 2022 and by the Pricing Committee of the Board of Directors of the Company on August&nbsp;12, 2022 (the &#147;<B>Resolutions</B>&#148;), and in accordance with Sections 2.1, 2.2 and 2.3 of the Indenture, dated as of
May&nbsp;22, 2014 (the &#147;<B>Indenture</B>&#148;; capitalized terms used herein and not otherwise defined shall have the meanings given to them in the Indenture), between Amgen Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), and
The Bank of New York Mellon Trust Company, N.A., as trustee (the &#147;<B>Trustee</B>&#148;), the following matters related to the issuance of the Company&#146;s 4.050% Senior Notes due 2029 (the &#147;<B>2029</B> <B>Notes</B>&#148;), 4.200% Senior
Notes due 2033 (the &#147;<B>2033</B> <B>Notes</B>&#148;) and 4.875% Senior Notes due 2053 (the &#147;<B>2053</B> <B>Notes</B>&#148; and, together with the 2029 Notes and the 2033 Notes, the &#147;<B>Notes</B>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.&nbsp;&nbsp;&nbsp;&nbsp;Attached hereto as <U>Annex A</U> is a true and correct copy of a specimen note (the &#147;<B>Form
of 2029 Note</B>&#148;) representing the 2029 Notes, attached hereto as <U>Annex B</U> is a true and correct copy of a specimen note (the &#147;<B>Form of 2033 Note</B>&#148;) representing the 2033 Notes and attached hereto as <U>Annex C</U> is a
true and correct copy of a specimen note (the &#147;<B>Form of 2053 Note</B>&#148;) representing the 2053 Notes. The Form of 2029 Note, the Form of 2033 Note and the Form of 2053 Note are herein collectively referred to as the &#147;<B>Forms of
Notes</B>.&#148; The Forms of Notes set forth certain of the terms required to be set forth in this Certificate pursuant to Section&nbsp;2.2 of the Indenture, and said terms are incorporated herein by reference. The 2029 Notes, the 2033 Notes and
the 2053 Notes are each a separate series of Securities under the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">2.&nbsp;&nbsp;&nbsp;&nbsp;The title of the
2029 Notes shall be the &#147;4.050% Senior Notes due 2029,&#148; the title of the 2033 Notes shall be the &#147;4.200% Senior Notes due 2033,&#148; and the title of the 2053 Notes shall be the &#147;4.875% Senior Notes due 2053.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.&nbsp;&nbsp;&nbsp;&nbsp;The 2029 Notes shall be issued at the initial offering price of 99.867% of the principal amount,
the 2033 Notes shall be issued at the initial offering price of 99.998% of the principal amount and the 2053 Notes shall be issued at the initial offering price of 99.982% of the principal amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4.&nbsp;&nbsp;&nbsp;&nbsp;The Company will initially issue $1,250,000,000 aggregate principal amount of the 2029 Notes,
$750,000,000 aggregate principal amount of the 2033 Notes and $1,000,000,000 aggregate principal amount of the 2053 Notes (in each case except for Notes authenticated and delivered upon registration of transfer of, in exchange for, or in lieu of,
other Notes pursuant to Sections 2.7, 2.8, 2.11, 3.6 or 9.6 of the Indenture). The Company may issue additional 2029 Notes, 2033 Notes and/or 2053 Notes from time to time after the date hereof, and such Notes will be treated as part of the
respective series of Notes for all purposes under the Indenture. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5.&nbsp;&nbsp;&nbsp;&nbsp;The Notes shall be issued as Global Securities
only and will be exchangeable for certificated notes (&#147;<B>Certificated Notes</B>&#148;) only if: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">DTC (x)&nbsp;notifies the Company that it is unwilling or unable to continue as depository for the Global
Securities or (y)&nbsp;at any time has ceased to be a clearing agency registered under the Exchange Act at a time when it is required to be registered and, in either case, the Company fails to appoint a successor depository registered as a clearing
agency under the Exchange Act within 90 days of notification to the Company or the Company becoming aware of DTC&#146;s ceasing to be so registered, as the case may be; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the Company, at its option, notifies the Trustee in writing to the effect that the Company elects to cause the
issuance of the Certificated Notes; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">there has occurred and is continuing an Event of Default with respect to the Notes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Certificated Notes delivered in exchange for any Global Security or beneficial interests in Global Securities will be
registered in the names, and issued in any approved denominations, requested by or on behalf of the depository (in accordance with its customary procedures). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.&nbsp;&nbsp;&nbsp;&nbsp;The Notes shall be denominated in Dollars and payments of principal and interest shall be made in
Dollars. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.&nbsp;&nbsp;&nbsp;&nbsp;In addition to the provisions set forth in Article IV of the Indenture, the following
additional provisions shall apply to the Notes and shall be incorporated into the Indenture with respect to the Notes: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.5 <B>Change of Control Offer</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(a)&nbsp;&nbsp;If a Change of Control Triggering Event occurs, unless the Company has exercised its option to redeem the
Notes as described in Section&nbsp;5 of the Security, the Company will be required to make an offer (the &#147;<B>Change of Control Offer</B>&#148;) to each Holder to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in
excess thereof) of that Holder&#146;s Notes on the terms set forth in such Security. In the Change of Control Offer, the Company shall be required to offer payment in cash equal to 101% of the aggregate principal amount of Notes repurchased, plus
accrued and unpaid interest, if any, on the Notes repurchased to the date of repurchase (the &#147;<B>Change of Control Payment</B>&#148;). Within 30 days following any Change of Control Triggering Event, a notice will be provided to Holders
describing the transaction that constitutes the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such
notice is provided (the &#147;<B>Change of Control Payment Date</B>&#148;); <I>provided, however</I>, that in no event will the Change of Control Payment Date occur prior to the date 90 days following the First Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(b)&nbsp;&nbsp;On the Change of Control Payment Date, the Company shall, to the extent lawful: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">accept for payment all Notes or portions of Notes properly tendered pursuant to the Change of Control Offer;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or
portions of Notes properly tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officer&#146;s
Certificate stating the aggregate principal amount of Notes or portions of Notes being repurchased. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(c)&nbsp;&nbsp;Notwithstanding the foregoing, the Company shall not repurchase any Notes if there has occurred and is
continuing on the Change of Control Payment Date an Event of Default under the Indenture, other than a Default in the payment of the Change of Control Payment upon a Change of Control Triggering Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(d)&nbsp;&nbsp;The Company will comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under the
Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the
provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the Notes, the Company will comply with those securities laws and regulations and will not be deemed to have breached its obligations under
the Change of Control Offer provisions of the Notes by virtue of any such conflict. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(e)&nbsp;&nbsp;If holders of not
less than 90% in aggregate principal amount of the outstanding Notes of the applicable series validly tender and do not withdraw such Notes in a Change Of Control Offer and the Company, or any third party making such an offer in lieu of the Company,
purchases all of the Notes validly tendered and not withdrawn by such holders, the Company or such third party will have the right, upon not less than 10 days nor more than 60 days&#146; prior notice, provided that such notice is given not more than
30 days following such repurchase pursuant to the Change Of Control Offer described above, to redeem all Notes that remain outstanding following such purchase on a date specified in such notice (the &#147;<B>Second Change Of Control Payment
Date</B>&#148;) and at a price in cash equal to 101% of the aggregate principal amount of Notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including, the Second Change Of Control Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(f)&nbsp;&nbsp;For the purposes of this Section&nbsp;4.5 only, the following definitions shall apply: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Beneficial Owner</B>&#148; shall be determined in accordance with Rules <FONT STYLE="white-space:nowrap">13d-3</FONT>
and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act or any successor provisions, except that a Person will be deemed to have beneficial ownership of all shares that Person has the right to acquire irrespective of whether that
right is exercisable immediately or only after the passage of time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control</B>&#148; means the
occurrence of any of the following: (1)&nbsp;the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any Person or Group (other than the Company or one of its Subsidiaries) becomes
the Beneficial Owner, directly or indirectly, of more than 50% of the Company&#146;s Voting Stock or other Voting Stock into which the Company&#146;s Voting Stock is reclassified, consolidated, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">
exchanged or changed, measured by voting power rather than number of shares; <I>provided</I>, <I>however</I>, that a Person shall not be deemed Beneficial Owner of, or to own beneficially,
(A)&nbsp;any securities tendered pursuant to a tender or exchange offer made by or on behalf of such Person or any of such Person&#146;s affiliates until such tendered securities are accepted for purchase or exchange thereunder, or (B)&nbsp;any
securities if such beneficial ownership (i)&nbsp;arises solely as a result of a revocable proxy delivered in response to a proxy or consent solicitation made pursuant to the applicable rules and regulations under the Exchange Act, and (ii)&nbsp;is
not also then reportable on Schedule 13D (or any successor schedule) under the Exchange Act; (2)&nbsp;the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more series of
related transactions, of all or substantially all of the Company&#146;s assets and the assets of the Company&#146;s Subsidiaries, taken as a whole, to one or more Persons or Groups (other than the Company or one of its Subsidiaries); <I>provided</I>
that none of the circumstances in this clause (2)&nbsp;will be a Change of Control if the Persons that beneficially own the Company&#146;s Voting Stock immediately prior to the transaction own, directly or indirectly, shares with a majority of the
total voting power of all outstanding voting securities of the surviving or transferee Person that are entitled to vote generally in the election of that Person&#146;s board of directors, managers or trustees immediately after the transaction; or
(3)&nbsp;the adoption of a plan relating to the Company&#146;s liquidation or dissolution. Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control under clause (1)&nbsp;above if (i)&nbsp;the Company becomes a
direct or indirect wholly-owned subsidiary of a holding company and (ii)&nbsp;(A) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are substantially the same as the holders of the
Company&#146;s Voting Stock immediately prior to that transaction or (B)&nbsp;immediately following that transaction no Person (other than a holding company satisfying the requirements of this sentence) is the Beneficial Owner, directly or
indirectly, of more than 50% of the Voting Stock of such holding company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control Triggering
Event</B>&#148; means the occurrence of both a Change of Control and a Rating Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Group</B>&#148; has the
meaning given by Section&nbsp;13(d) and 14(d) of the Exchange Act or any successor provisions and includes any group acting for the purpose of acquiring, holding or disposing of securities within the meaning of Rule
<FONT STYLE="white-space:nowrap">13d-5(b)(1)</FONT> under the Exchange Act or any successor provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Investment Grade Rating</B>&#148; means a rating equal to or higher than Baa3 (or the equivalent) by Moody&#146;s and
<FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P, and the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Moody&#146;s</B>&#148; means Moody&#146;s Investors Service, Inc., and its successors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Person</B>&#148; has the meaning given by Section&nbsp;13(d) and 14(d) of the Exchange Act or any successor
provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Rating Agencies</B>&#148; means (1)&nbsp;each of Moody&#146;s and S&amp;P; and (2)&nbsp;if either
Moody&#146;s or S&amp;P ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company&#146;s control, a &#147;nationally recognized statistical rating organization&#148; within the meaning of
Section&nbsp;3(a)(62) of the Exchange Act selected by the Company (as certified by a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">
resolution of the Board of Directors) as a replacement agency for Moody&#146;s or S&amp;P, or both of them, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Rating Event</B>&#148; means the rating on the applicable series of Notes is lowered by both of the Rating Agencies
and the applicable series of Notes is rated below an Investment Grade Rating by both of the Rating Agencies on any day during the period commencing 60 days prior to the first public notice of the occurrence of a Change of Control or the
Company&#146;s intention to effect a Change of Control and ending 60 days following consummation of such Change of Control (which period will be extended so long as the rating of the applicable series of Notes is under publicly announced
consideration for a possible downgrade by any of the Rating Agencies). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>S&amp;P</B>&#148; means
Standard&nbsp;&amp; Poor&#146;s Rating Services, a division of The McGraw-Hill Companies, Inc., and its successors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Voting Stock</B>&#148; as applied to stock of any Person, means shares, interests, participations or other
equivalents in the equity interest (however designated) in such Person having ordinary voting power for the election of a majority of the directors (or the equivalent) of such Person, other than shares, interests, participations or other equivalents
having such power only by reason of the occurrence of a contingency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.6 <B>Limitation on Liens</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(a) The Company shall not, nor shall it permit any of its Subsidiaries to, create or incur any Lien on any of their respective
Properties, whether now owned or hereafter acquired, or upon any income or profits therefrom, in order to secure any Indebtedness of the Company, without effectively providing that each series of the Notes shall be equally and ratably secured until
such time as such Indebtedness is no longer secured by such Lien, except: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;Liens existing as of the First
Issue Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;Liens granted after the First Issue Date on any of the Company or any of its Subsidiaries&#146;
Properties securing Indebtedness of the Company created in favor of the Holders of the Notes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;Liens securing
Indebtedness of the Company which are incurred to extend, renew or refinance Indebtedness which is secured by Liens permitted to be incurred under the Indenture; <I>provided</I> that those Liens do not extend to or cover any of the Company or any of
its Subsidiaries&#146; Property other than the Property securing the Indebtedness being refinanced and that the principal amount of such Indebtedness does not exceed the principal amount of the Indebtedness being refinanced; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;Liens created in substitution of or as replacements for any Liens permitted by the preceding clauses
(1)&nbsp;through (3) directly above, <I>provided</I> that, based on a good faith determination of an Officer of the Company, the Property encumbered under any such substitute or replacement Lien is substantially similar in nature to the Property
encumbered by the otherwise permitted Lien which is being replaced; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;Permitted Liens. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, the Company and
any of its Subsidiaries may, without securing any series of Notes, create or incur Liens which would otherwise be subject to the restrictions set forth in the preceding paragraph, if after giving effect thereto, Exempted Debt does not exceed the
greater of (x) 35% of Consolidated Net Worth calculated as of the date of the creation or incurrence of the Lien or (y) 35% of Consolidated Net Worth calculated as of the First Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;4.7 <B>Limitation on Sale and Lease-Back Transactions</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall not and shall not permit any of its Subsidiaries to, enter into any sale and
lease-back transaction for the sale and leasing back of any Property, whether now owned or hereafter acquired, of the Company or any Subsidiary of the Company, unless: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;such transaction was entered into prior to the First Issue Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;such transaction was for the sale and leasing back of any Property by a Subsidiary of the Company to the Company;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;such transaction involves a lease for less than three years; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;the Company would be entitled to incur Indebtedness secured by a mortgage on the property to be leased in an
amount equal to the Attributable Liens with respect to such sale and lease-back transaction without equally and ratably securing the Notes pursuant to Section&nbsp;4.6; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:12pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;the Company applies an amount equal to the fair value of the proceeds of the Property sold to the purchase of
Property or to the retirement of long-term Indebtedness of the Company or any of its Subsidiaries within 120 days of the effective date of any such sale and lease-back transaction. In lieu of applying such amount to such retirement, the Company may,
or may cause any of its Subsidiaries to, deliver debt securities to the Trustee therefor for cancellation, such debt securities to be credited at the cost thereof to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, the Company and any of its Subsidiaries may enter into any sale and
lease-back transaction which would otherwise be subject to the foregoing restrictions if after giving effect thereto and at the time of determination, Exempted Debt does not exceed the greater of (a) 35% of Consolidated Net Worth calculated as of
the closing date of the sale and lease-back transaction or (b) 35% of Consolidated Net Worth calculated as of the First Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">8.&nbsp;&nbsp;&nbsp;&nbsp;In addition to the definitions set forth in Article&nbsp;I of the Indenture, each of the Notes
shall include the following additional definitions, which, in the event of a conflict with the definition of terms in the Indenture, shall control: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Attributable Liens</B>&#148; means in connection with a sale and lease-back transaction the lesser of: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(1)&nbsp;&nbsp;&nbsp;&nbsp;the fair market value of the assets subject to such transaction; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(2)&nbsp;&nbsp;&nbsp;&nbsp;the present value (discounted at a rate per annum
equal to the average interest borne by all outstanding debt securities issued under the Indenture (which may include debt securities in addition to the Notes) determined on a weighted average basis and compounded semi-annually) of the obligations of
the lessee for rental payments during the term of the related lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Business Day</B>&#148; means any day except
a Saturday, Sunday or a legal holiday in the City of New York, New York (or in connection with any payment, the place of payment) on which banking institutions are authorized or required by law, regulation or executive order to close. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Consolidated Net Worth</B>&#148; means, as of any date of determination, the Stockholders&#146; Equity of the Company
and its Consolidated Subsidiaries on that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Consolidated Subsidiary</B>&#148; means, as of any date of
determination and with respect to any Person, any Subsidiary of that Person whose financial data is, in accordance with GAAP, reflected in that Person&#146;s consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Credit Facilities</B>&#148; means, one or more debt facilities (including, without limitation, the Revolving Credit
Agreement) or commercial paper facilities, in each case, with banks or other institutional lenders providing for revolving credit loans, term loans, receivables financing (including through the sale of receivables to such lenders or to special
purpose entities formed to borrow from such lenders against such receivables) or letters of credit, in each case, as amended, restated, modified, renewed, refunded, replaced (whether upon or after termination or otherwise) or refinanced (including
by means of sales of debt securities to institutional investors) in whole or in part from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Exempted
Debt</B>&#148; means the sum of the following as of the date of determination: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(1)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness of
the Company incurred after the First Issue Date and secured by Liens not permitted by Section&nbsp;4.6(a) above; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(2)&nbsp;&nbsp;&nbsp;&nbsp;Attributable Liens of the Company and any of its Subsidiaries in respect of sale and lease-back
transactions entered into after the First Issue Date pursuant to Section&nbsp;4.7(b) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Finance
Lease</B>&#148; means, as to any Person, a lease of any Property by that Person as lessee that is, or should be recorded as a &#147;finance lease&#148; on the balance sheet of that Person prepared in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>First Issue Date&#148;</B> means August&nbsp;18, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>GAAP</B>&#148; means accounting principles generally accepted in the United States set forth in the Accounting
Standards Codification of the Financial Accounting Standards Board or in such other documents by such other entity as have been approved by a significant segment of the accounting profession, which are in effect as of the date of determination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Governmental Agency</B>&#148; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(1)&nbsp;&nbsp;any foreign, federal, state, county or municipal government, or political subdivision thereof; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(2)&nbsp;&nbsp;any governmental or quasi-governmental agency, authority,
board, bureau, commission, department, instrumentality or public body; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(3)&nbsp;&nbsp;any court or administrative
tribunal; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(4)&nbsp;&nbsp;with respect to any Person, any arbitration tribunal or other nongovernmental authority to
whose jurisdiction that Person has consented. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Hedging Obligations</B>&#148; means, with respect to any specified
Person, the obligations of such Person under: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(1)&nbsp;&nbsp;interest rate swap agreements (whether from fixed to
floating or from floating to fixed), interest rate cap agreements and interest rate collar agreements; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(2)&nbsp;&nbsp;other agreements or arrangements designed to manage interest rates or interest rate risk; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(3)&nbsp;&nbsp;other agreements or arrangements designed to protect such Person against fluctuations in currency exchange
rates or commodity prices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Indebtedness</B>&#148; of any Person means, without duplication, any indebtedness,
whether or not contingent, in respect of borrowed money or evidenced by bonds, notes, debentures or similar instruments or letters of credit (or reimbursement agreements with respect thereto) or representing the balance deferred and unpaid of the
purchase price of any Property (including pursuant to Finance Leases), except any such balance that constitutes an accrued expense or trade payable, if and to the extent any of the foregoing indebtedness would appear as a liability upon a balance
sheet of such Person prepared on a consolidated basis in accordance with GAAP (but does not include contingent liabilities which appear only in a footnote to a balance sheet), and shall also include, to the extent not otherwise included, the
guaranty of items which would be included within this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Laws</B>&#148; means, collectively, all
foreign, federal, state and local statutes, treaties, rules, regulations, ordinances, codes and administrative or controlling precedents of any Governmental Agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Lien</B>&#148; means any lien, security interest, charge or encumbrance of any kind (including any conditional sale
or other title retention agreement, any lease in the nature thereof, and any agreement to give any security interest). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Make-Whole Amount</B>&#148; means the excess of (1)&nbsp;the net present value, on the redemption date, of the
principal being redeemed or paid and the amount of interest (exclusive of interest accrued to the date of redemption) that would have been payable if such redemption had not been made (calculated as if the maturity date of such series of Notes was
the par call date relating to such series of Notes, to the extent applicable), over (2)&nbsp;the aggregate principal amount of such series of Notes being redeemed or paid. Net present value shall be determined by discounting, on a semi-annual basis,
such principal and interest at the Reinvestment Rate (as defined below and as determined on the third Business Day preceding the date of redemption) from the respective dates </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">
on which such principal and interest would have been payable if such redemption had not been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Permitted Liens</B>&#148; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(1)&nbsp;&nbsp;Liens securing Indebtedness under Credit Facilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(2)&nbsp;&nbsp;Liens on accounts receivable, merchandise inventory, equipment, and patents, trademarks, trade names and other
intangibles, securing Indebtedness of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(3)&nbsp;&nbsp;Liens on any assets of the Company, any of its
Subsidiaries&#146; assets, or the assets of any joint venture to which the Company or any of its Subsidiaries is a party, created solely to secure obligations incurred to finance the refurbishment, improvement or construction of such asset, which
obligations are incurred no later than 24 months after completion of such refurbishment, improvement or construction, and all renewals, extensions, refinancings, replacements or refundings of such obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(4)&nbsp;&nbsp;(a) Liens given to secure the payment of the purchase price incurred in connection with the acquisition
(including acquisition through merger or consolidation) of Property (including shares of stock), including Finance Lease transactions in connection with any such acquisition, and (b)&nbsp;Liens existing on Property at the time of acquisition thereof
or at the time of acquisition by the Company or one of its Subsidiaries of any Person then owning such Property whether or not such existing Liens were given to secure the payment of the purchase price of the Property to which they attach;
<I>provided</I> that, with respect to clause (a), the Liens shall be given within 24 months after such acquisition and shall attach solely to the Property acquired or purchased and any improvements then or thereafter placed thereon; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(5)&nbsp;&nbsp;Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs
duties in connection with the importation of goods; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(6)&nbsp;&nbsp;Liens upon specific items of inventory or other goods
and proceeds of any Person securing such Person&#146;s obligations in respect of bankers&#146; acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(7)&nbsp;&nbsp;Liens securing reimbursement obligations with respect to letters of credit that encumber documents and other
Property relating to such letters of credit and the products and proceeds thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(8)&nbsp;&nbsp;Liens on <FONT
STYLE="white-space:nowrap">key-man</FONT> life insurance policies granted to secure Indebtedness of the Company against the cash surrender value thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(9)&nbsp;&nbsp;Liens encumbering customary initial deposits and margin deposits and other Liens in the ordinary course of
business, in each case securing Hedging Obligations and forward contract, option, futures contracts, futures options or similar agreements or arrangements designed to protect the Company or any of its Subsidiaries from fluctuations in interest
rates, currencies or the price of commodities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(10)&nbsp;&nbsp;Liens arising out of conditional sale, title retention,
consignment or similar arrangements for the sale of goods entered into by Company or any of its Subsidiaries in the ordinary course of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><FONT STYLE="white-space:nowrap">(11)&nbsp;&nbsp;pre-existing</FONT> Liens on assets acquired by the Company or any of its
Subsidiaries after the First Issue Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(12)&nbsp;&nbsp;Liens in favor of the Company or in favor of any of its
Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(13)&nbsp;&nbsp;inchoate Liens incident to construction or maintenance of real property, or Liens incident
to construction or maintenance of real property, now or hereafter filed of record for sums not yet delinquent or being contested in good faith, if reserves or other appropriate provisions, if any, as shall be required by GAAP shall have been made
therefore; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(14)&nbsp;&nbsp;statutory Liens arising in the ordinary course of business with respect to obligations which
are not delinquent or are being contested in good faith, if reserves or other appropriate provisions, if any, as shall be required by GAAP shall have been made therefore; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(15)&nbsp;&nbsp;Liens consisting of pledges or deposits to secure obligations under workers&#146; compensation laws or similar
legislation, including Liens of judgments thereunder which are not currently dischargeable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(16)&nbsp;&nbsp;Liens
consisting of pledges or deposits of Property to secure performance in connection with operating leases made in the ordinary course of business to which Company or any of its Subsidiaries is a party as lessee, <I>provided</I> the aggregate value of
all such pledges and deposits in connection with any such lease does not at any time exceed 16<SUP STYLE="vertical-align:top">2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the annual fixed rentals payable under such lease; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(17)&nbsp;&nbsp;Liens consisting of deposits of Property to secure statutory obligations of the Company or statutory
obligations of any of its Subsidiaries in the ordinary course of its business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(18)&nbsp;&nbsp;Liens consisting of
deposits of Property to secure (or in lieu of) surety, appeal or customs bonds in proceedings to which the Company or any of its Subsidiaries is a party in the ordinary course of its business, but not in excess of $75,000,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(19)&nbsp;&nbsp;purchase money Liens or purchase money security interests upon or in any Property acquired or held by Company
or any of its Subsidiaries in the ordinary course of business to secure the purchase price of such Property or to secure Indebtedness incurred solely for the purpose of financing the acquisition of such Property; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(20)&nbsp;&nbsp;Liens on an asset created in connection with the acquisition, construction or development of additions,
extensions or improvements to such asset which shall be financed by obligations described in Sections 142, 144(a) or 144(c) of the Internal Revenue Code of 1986, as amended, or by obligations entitled to substantially similar tax benefits under
other legislation or regulations in effect from time to time; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">(21)&nbsp;&nbsp;Liens on Property subject to escrow or
similar arrangements established in connection with litigation settlements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Person</B>&#148; means any individual, corporation, partnership,
joint venture, association, limited liability company, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Property</B>&#148; means any property or asset, whether real, personal or mixed, or tangible or intangible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Reinvestment Rate</B>&#148; means, for the 2029 Notes, 0.200%, for the 2033 Notes, 0.250% and for the 2053 Notes,
0.300%, in each case plus the weekly yield for the most recent week set forth in the most recent Statistical Release (as defined below) for the constant maturity U.S. Treasury security (rounded to the nearest month) corresponding to the remaining
life to maturity, as of the payment date of the principal being redeemed or paid.&nbsp;If no maturity exactly corresponds to such maturity, yields for the two published maturities most closely corresponding to such maturity shall be calculated
pursuant to the immediately preceding sentence and the Reinvestment Rate shall be interpolated or extrapolated from such yields on a straight-line basis, rounding in each of such relevant periods to the nearest month.&nbsp;For the purpose of
calculating the Reinvestment Rate, the most recent Statistical Release published prior to the date of determination of the Make-Whole Amount shall be used. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Revolving Credit Agreement</B>&#148; means the Second Amended and Restated Credit Agreement, dated as of
December&nbsp;12, 2019, among the Company, the banks therein named, Citibank, N.A., as administrative agent, JPMorgan Chase Bank, N.A., as syndication agent, and Citibank, N.A., JPMorgan Chase Bank, N.A., Barclays Bank PLC, BofA Securities, Inc.,
Goldman Sachs Bank USA and Morgan Stanley Senior Funding, Inc., as joint lead arrangers and joint book runners, as such agreement may be further amended (including any amendment, restatement, refinancing and successors thereof), supplemented or
otherwise modified from time to time, including any increase in the principal amount of the obligations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Statistical Release</B>&#148; means the statistical release designated &#147;H.15&#148; or any comparable online data
source or publication which is made available by the Federal Reserve System and which establishes yields on actively traded U.S. government securities adjusted to constant maturities, or, if such Statistical Release is not published at the time of
any determination under the Indenture, then such other reasonably comparable index which shall be designated by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Stockholders&#146; Equity</B>&#148; means, as of any date of determination, stockholders&#146; equity as of that date
determined in accordance with GAAP; <I>provided</I> that there shall be excluded from Stockholders&#146; Equity any amount attributable to capital stock that is, directly or indirectly, required to be redeemed or repurchased by the issuer thereof at
a specified date or upon the occurrence of specified events or at the election of the holder thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Subsidiary</B>&#148; of any specified person means any corporation, association or other business entity of which
more than 50% of the total voting power of shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or
indirectly, by such person or one or more of the other Subsidiaries of that person or a combination thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">9.&nbsp;&nbsp;&nbsp;&nbsp;Section 9.1(h) of the Indenture shall be amended
and restated solely with respect to the Notes as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;to make any change that does not adversely affect
the rights of any Securityholder in any material respect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">10.&nbsp;&nbsp;Pursuant to Section&nbsp;3.4 of the Indenture,
solely with respect to the Notes, notices of redemption sent by the Company pursuant to the Indenture may be conditional. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">11.&nbsp;&nbsp;The Depository for the Notes shall be The Depository Trust Company (&#147;<B>DTC</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">12.&nbsp;&nbsp;The undersigned is authorized to approve the form, terms and conditions of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">13.&nbsp;&nbsp;The undersigned has read the provisions of the Indenture, including the covenants and conditions precedent,
pertaining to the issuance of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">14.&nbsp;&nbsp;In connection with this Certificate, the undersigned has
examined the documents, corporate records and certificates and has made such inquiries of the other officers of the Company, which he or she has deemed necessary to enable him or her to express an informed opinion as to whether or not such comments
and conditions have been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:11%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">15.&nbsp;&nbsp;In the opinion of the undersigned, all of the conditions and
covenants related to the issuance of the Notes have been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[<I>Signature follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>IN WITNESS WHEREOF</B>, the undersigned has executed this Officer&#146;s
Certificate as of the date first set forth above. </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Justin G. Claeys</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: &nbsp;Justin G. Claeys</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President, Finance and Treasurer</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annex A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Form of 2029 Note </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[Face of Note] </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="right">CUSIP 031162DH0 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>4.050% Senior Notes due 2029 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">No. __</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$____________</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMGEN INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">promises to pay to CEDE&nbsp;&amp; CO. or registered assigns, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">the principal sum of <B>___________________ DOLLARS</B> on August 18, 2029. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;18 and August&nbsp;18 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Record Dates: 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day prior to February&nbsp;18 and August&nbsp;18 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Dated:&nbsp;&nbsp;<B>August</B><B></B><B>&nbsp;18, 2022</B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"><B>AMGEN INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the Notes referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in the within-mentioned Indenture: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>THE BANK OF NEW YORK
MELLON</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>TRUST COMPANY, N.A.</B>, as Trustee </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Officer</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Authentication&nbsp;Date: _______________________ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[REVERSE SIDE OF NOTE] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>4.050% SENIOR NOTES DUE 2029 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
OR A NOMINEE OF THE DEPOSITORY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY NOT BE TRANSFERRED EXCEPT
AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY, BY A NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY OR BY THE DEPOSITORY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR A NOMINEE OF SUCH A SUCCESSOR
DEPOSITORY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE ISSUER OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY
PAYMENT HEREON IS MADE TO CEDE&nbsp;&amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
SINCE THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Capitalized terms used herein have the meanings assigned
to them in the Indenture referred to below unless otherwise indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">INTEREST. Amgen Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), promises to pay interest on
the principal amount of this Note at 4.050% per annum from August&nbsp;18, 2022 until maturity. The Company will pay interest in cash semi-annually in arrears on February&nbsp;18 and August 18 of each year, or if any such day is not a Business Day,
on the next succeeding Business Day (each, an &#147;<B>Interest Payment Date</B>&#148;). Interest on the Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from the date of issuance;
provided that the first Interest Payment Date shall be February&nbsp;18, 2023; provided further that after February 18, 2023, if there is no existing Default in the payment of interest, and if this Note is authenticated between a record date
referred to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date. The interest rate will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT>
year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> calendar months. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">METHOD OF PAYMENT. The Company will pay interest on the Notes (except defaulted interest) to the Persons who
are registered Holders of Notes at the close of business on the day that is 15 days prior to the next succeeding Interest Payment Date (whether or not such day is a Business Day), even if such Notes are canceled after such record date and on or
before such Interest Payment Date, except as </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
provided in Section&nbsp;2.13 of the Indenture with respect to defaulted interest. The Notes will be payable as to principal and interest at the office or agency of the Company maintained for
such purpose in the Borough of Manhattan, the City and State of New York (or, if the Company fails to maintain such office or agency, at the corporate trust office of the trustee in New York, New York or if the trustee does not maintain an office in
New York, at the office of a paying agent in New York), or, at the option of the Company, payment of interest may be made by check mailed to the Holders at their addresses set forth in the register of Holders<I>; provided</I> that payment by wire
transfer of immediately available funds will be required with respect to principal of and interest on all Global Securities and all other Notes the Holders of which will have provided wire transfer instructions to the Company or the Paying Agent.
Such payment will be in the currency of the United States of America. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company, N.A., the Trustee under
the Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">INDENTURE. The terms of the Notes include those stated in the Indenture dated May&nbsp;22, 2014, between the
Company and the Trustee (the &#147;<B>Indenture</B>&#148;), and those made part of the Indenture by the Officer&#146;s Certificate dated August&nbsp;18, 2022, delivered pursuant thereto (the &#147;<B>Officer&#146;s Certificate</B>&#148;) and the
TIA. The Notes are subject to all such terms, and the Holders are referred to the Indenture and the TIA for a statement of them. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">OPTIONAL REDEMPTION. At any time prior to maturity, the Company will have the option to redeem all or a part
of the Notes upon not less than 10 nor more than 60 days&#146; notice. If the Notes are redeemed before June&nbsp;18, 2029 (two months prior to the maturity date of the Notes), the redemption price will equal the sum of (1) 100% of the principal
amount of any Notes being redeemed, plus accrued and unpaid interest to, but not including, the redemption date, and (2)&nbsp;the Make-Whole Amount. If the Notes are redeemed on or after June&nbsp;18, 2029 (two months prior to the maturity date of
the Notes), the redemption price will equal 100% of the principal amount being redeemed, plus accrued and unpaid interest to, but not including, the redemption date. Unless the Company defaults in the payment of the redemption price, interest will
cease to accrue on the Notes or portions thereof called for redemption on the applicable redemption date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">NOTICE OF REDEMPTION. Notice of redemption will be mailed at least 10 days but not more than 60 days before
the redemption date to each Holder whose Notes are to be redeemed at its registered address, except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the
Notes or a satisfaction or discharge of the Indenture. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000, unless all of the Notes held by a Holder are to
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
be redeemed. Notices of redemption for the Notes may be conditional. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">MANDATORY REDEMPTION. Except as provided in Section&nbsp;8 below, the Company is not required to make
mandatory redemption or sinking fund payments with respect to the Notes. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">CHANGE OF CONTROL TRIGGERING EVENT. In the event of a Change of Control Triggering Event, the Holders may
require the Company to purchase for cash all or a portion of their Notes at a purchase price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest, if any, pursuant to the provisions of Section&nbsp;7 of the
Officer&#146;s Certificate. If holders of not less than 90% in aggregate principal amount of the outstanding Notes validly tender and do not withdraw such Notes in a Change Of Control Offer and the Company, or any third party making such an offer in
lieu of the Company, purchases all of the Notes validly tendered and not withdrawn by such holders, the Company or such third party will have the right, upon not less than 10 days nor more than 60 days&#146; prior notice, provided that such notice
is given not more than 30 days following such repurchase pursuant to the Change Of Control Offer described above, to redeem all Notes that remain outstanding following such purchase on a date specified in such notice (the &#147;<B>Second Change Of
Control Payment Date</B>&#148;) and at a price in cash equal to 101% of the aggregate principal amount of Notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including, the Second Change Of Control Payment
Date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DEFEASANCE PRIOR TO MATURITY. The Indenture contains provisions for defeasance of (i)&nbsp;the entire
indebtedness of the Notes or (ii)&nbsp;certain covenants and Events of Default with respect to the Notes, in each case upon compliance with certain conditions set forth therein. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">RESTRICTIVE COVENANTS. The Indenture and the Officer&#146;s Certificate impose certain limitations on the
Company and its Subsidiaries, including limitations on the Company&#146;s and its Subsidiaries&#146; ability to create or incur certain Liens on any of their respective properties or assets and to enter into certain sale and lease-back transactions
and on the Company&#146;s ability to engage in mergers or consolidations or the conveyance, transfer or lease of all or substantially all of its properties and assets. These limitations are subject to a number of important qualifications and
exceptions and reference is made to the Indenture and the Officer&#146;s Certificate for a description thereof. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without coupons in denominations of
$2,000 and integral multiples of $1,000. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and
transfer documents and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Note or portion of a Note selected for redemption, except
for the </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
unredeemed portion of any Note being redeemed in part. Also, the Company need not exchange or register the transfer of any Notes for a period of 15 days before a selection of Notes to be redeemed
or during the period between a record date and the corresponding Interest Payment Date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its owner for all purposes.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">AMENDMENT, SUPPLEMENT AND WAIVER. Subject to certain exceptions, the Indenture or the Notes may be amended
or supplemented with the consent of the Holders of at least a majority in aggregate principal amount of the then outstanding Notes voting as a single class, and any existing Default or Event or Default or compliance with any provision of the
Indenture or the Notes may be waived with the consent of the Holders of a majority in aggregate principal amount of the then outstanding Notes voting as a single class. Without the consent of any Holder of a Note, the Indenture or the Notes may be
amended or supplemented to cure any ambiguity, defect or inconsistency; to comply with Article V of the Indenture; to provide for uncertificated Notes in addition to or in place of certificated Notes; to add guarantees with respect to the Notes or
secure the Notes; to surrender any of the Company&#146;s rights or powers under the Indenture; to add covenants or events of default for the benefit of the Holders of the Notes; to comply with the applicable procedures of the applicable depositary;
to make any change that would not adversely affect the rights under the Indenture of any such Holder in any material respect; to provide for the issuance of and establish the form and terms and conditions of Notes of any series as permitted by the
Indenture; to evidence and provide for the acceptance of appointment under the Indenture by a successor trustee with respect to the Notes and to add to or change any of the provisions of the Indenture necessary to provide for the administration of
the trusts in the Indenture by more than one trustee; or to comply with the requirements of the SEC in order to effect or maintain the qualification of the Indenture under the TIA. No amendment to cure any ambiguity, defect or inconsistency in the
Indenture made solely to conform the Indenture to the description of notes contained in the Prospectus Supplement related to the Notes, dated August&nbsp;15, 2022, will be deemed to adversely affect the interests of the Holders of the Notes.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DEFAULTS AND REMEDIES. If an Event of Default shall occur and be continuing, the principal of the Notes may
be declared (or, in certain cases, shall ipso facto become) due and payable in the manner and with the effect provided in the Indenture. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">TRUSTEE DEALINGS WITH COMPANY. The Trustee under the Indenture, in its individual or any other capacity, may
deal with the Company or an Affiliate of the Company with the same rights it would have if it were not Trustee. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">NO RECOURSE AGAINST OTHERS. A director, officer, employee or stockholder of the Company shall not have any
liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
or by reason of, such obligations or their creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for the issuance
of the Notes. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">AUTHENTICATION. This Note will not be valid until authenticated by the manual signature of the Trustee or an
authenticating agent. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM
(= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(19)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification
Procedures, the Company has caused CUSIP numbers to be printed on the Notes, and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed
on the Notes or as contained in any notice of redemption, and reliance may be placed only on the other identification numbers placed thereon. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(20)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">GOVERNING LAW. THE INDENTURE AND THIS NOTE, INCLUDING ANY CLAIM OR CONTROVERSY ARISING OUT OF OR RELATED TO
THE INDENTURE OR THIS NOTE, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Company will furnish to any
Holder upon written request and without charge a copy of the Indenture and/or the Officer&#146;s Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Requests may be made
to</I></B>: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Amgen Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">One
Amgen Center Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Thousand Oaks, CA 91320-1799 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">To assign this Note, fill in the form below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" NOWRAP>(I)&nbsp;or&nbsp;(we)&nbsp;assign&nbsp;and&nbsp;transfer&nbsp;this&nbsp;Note&nbsp;to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Insert assignee&#146;s legal name)</TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">(Insert assignee&#146;s soc. sec. or tax I.D. no.) </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">(Print or type assignee&#146;s name,
address and zip code) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">and irrevocably appoint _______________________________________________________________ to transfer this Note on the books of the
Company. The agent may substitute another to act for him. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Date: ____________________ </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="60%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">Your&nbsp;Signature:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(Sign exactly as your name appears on the face of this Note)</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Signature Guarantee*: ______________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annex B </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Form of 2033 Note </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[Face of Note] </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="right">CUSIP 031162DJ6 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>4.200% Senior Notes due 2033 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">No. __</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$____________</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMGEN INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">promises to pay to CEDE&nbsp;&amp; CO. or registered assigns, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">the principal sum of <B>___________________ DOLLARS</B> on March&nbsp;1, 2033. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Interest Payment Dates: March&nbsp;1 and September&nbsp;1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Record Dates: 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day prior to March&nbsp;1 and September&nbsp;1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Dated:&nbsp;&nbsp;<B>August 18, 2022</B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"><B>AMGEN INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">This is one of the Notes referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">in the within-mentioned Indenture: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:3%; text-indent:-2%; font-size:12pt; font-family:Times New Roman"><B>THE BANK OF NEW YORK MELLON</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3%; text-indent:-2%; font-size:12pt; font-family:Times New Roman"><B>TRUST COMPANY, N.A.</B>, as Trustee </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Authorized Officer</P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Authentication&nbsp;Date: _______________________ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[REVERSE SIDE OF NOTE] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>4.200% SENIOR NOTES DUE 2033 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
OR A NOMINEE OF THE DEPOSITORY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY NOT BE TRANSFERRED EXCEPT
AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY, BY A NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY OR BY THE DEPOSITORY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR A NOMINEE OF SUCH A SUCCESSOR
DEPOSITORY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE ISSUER OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY
PAYMENT HEREON IS MADE TO CEDE&nbsp;&amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
SINCE THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Capitalized terms used herein have the meanings assigned
to them in the Indenture referred to below unless otherwise indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">INTEREST. Amgen Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), promises to pay interest on
the principal amount of this Note at 4.200% per annum from August 18, 2022 until maturity. The Company will pay interest in cash semi-annually in arrears on March&nbsp;1 and September&nbsp;1 of each year, or if any such day is not a Business Day, on
the next succeeding Business Day (each, an &#147;<B>Interest Payment Date</B>&#148;). Interest on the Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from the date of issuance; provided
that the first Interest Payment Date shall be March&nbsp;1, 2023; provided further that after March&nbsp;1, 2023, if there is no existing Default in the payment of interest, and if this Note is authenticated between a record date referred to on the
face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date. The interest rate will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT
STYLE="white-space:nowrap">30-day</FONT> calendar months. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">METHOD OF PAYMENT. The Company will pay interest on the Notes (except defaulted interest) to the Persons who
are registered Holders of Notes at the close of business on the day that is 15 days prior to the next succeeding Interest Payment Date (whether or not such day is a Business Day), even if such Notes are canceled after such record date and on or
before such Interest Payment Date, except as </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
provided in Section&nbsp;2.13 of the Indenture with respect to defaulted interest. The Notes will be payable as to principal and interest at the office or agency of the Company maintained for
such purpose in the Borough of Manhattan, the City and State of New York (or, if the Company fails to maintain such office or agency, at the corporate trust office of the trustee in New York, New York or if the trustee does not maintain an office in
New York, at the office of a paying agent in New York), or, at the option of the Company, payment of interest may be made by check mailed to the Holders at their addresses set forth in the register of Holders<I>; provided</I> that payment by wire
transfer of immediately available funds will be required with respect to principal of and interest on all Global Securities and all other Notes the Holders of which will have provided wire transfer instructions to the Company or the Paying Agent.
Such payment will be in the currency of the United States of America. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company, N.A., the Trustee under
the Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">INDENTURE. The terms of the Notes include those stated in the Indenture dated May&nbsp;22, 2014, between the
Company and the Trustee (the &#147;<B>Indenture</B>&#148;), and those made part of the Indenture by the Officer&#146;s Certificate dated August 18, 2022, delivered pursuant thereto (the &#147;<B>Officer&#146;s Certificate</B>&#148;) and the TIA. The
Notes are subject to all such terms, and the Holders are referred to the Indenture and the TIA for a statement of them. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">OPTIONAL REDEMPTION. At any time prior to maturity, the Company will have the option to redeem all or a part
of the Notes upon not less than 10 nor more than 60 days&#146; notice. If the Notes are redeemed before December&nbsp;1, 2032 (three months prior to the maturity date of the Notes), the redemption price will equal the sum of (1) 100% of the
principal amount of any Notes being redeemed, plus accrued and unpaid interest to, but not including, the redemption date, and (2)&nbsp;the Make-Whole Amount. If the Notes are redeemed on or after December&nbsp;1, 2032 (three months prior to the
maturity date of the Notes), the redemption price will equal 100% of the principal amount being redeemed, plus accrued and unpaid interest to, but not including, the redemption date. Unless the Company defaults in the payment of the redemption
price, interest will cease to accrue on the Notes or portions thereof called for redemption on the applicable redemption date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">NOTICE OF REDEMPTION. Notice of redemption will be mailed at least 10 days but not more than 60 days before
the redemption date to each Holder whose Notes are to be redeemed at its registered address, except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the
Notes or a satisfaction or discharge of the Indenture. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000, unless all of the Notes held by a Holder are to
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
be redeemed. Notices of redemption for the Notes may be conditional. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">MANDATORY REDEMPTION. Except as provided in Section&nbsp;8 below, the Company is not required to make
mandatory redemption or sinking fund payments with respect to the Notes. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">CHANGE OF CONTROL TRIGGERING EVENT. In the event of a Change of Control Triggering Event, the Holders may
require the Company to purchase for cash all or a portion of their Notes at a purchase price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest, if any, pursuant to the provisions of Section&nbsp;7 of the
Officer&#146;s Certificate. If holders of not less than 90% in aggregate principal amount of the outstanding Notes validly tender and do not withdraw such Notes in a Change Of Control Offer and the Company, or any third party making such an offer in
lieu of the Company, purchases all of the Notes validly tendered and not withdrawn by such holders, the Company or such third party will have the right, upon not less than 10 days nor more than 60 days&#146; prior notice, provided that such notice
is given not more than 30 days following such repurchase pursuant to the Change Of Control Offer described above, to redeem all Notes that remain outstanding following such purchase on a date specified in such notice (the &#147;<B>Second Change Of
Control Payment Date</B>&#148;) and at a price in cash equal to 101% of the aggregate principal amount of Notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including, the Second Change Of Control Payment
Date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DEFEASANCE PRIOR TO MATURITY. The Indenture contains provisions for defeasance of (i)&nbsp;the entire
indebtedness of the Notes or (ii)&nbsp;certain covenants and Events of Default with respect to the Notes, in each case upon compliance with certain conditions set forth therein. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">RESTRICTIVE COVENANTS. The Indenture and the Officer&#146;s Certificate impose certain limitations on the
Company and its Subsidiaries, including limitations on the Company&#146;s and its Subsidiaries&#146; ability to create or incur certain Liens on any of their respective properties or assets and to enter into certain sale and lease-back transactions
and on the Company&#146;s ability to engage in mergers or consolidations or the conveyance, transfer or lease of all or substantially all of its properties and assets. These limitations are subject to a number of important qualifications and
exceptions and reference is made to the Indenture and the Officer&#146;s Certificate for a description thereof. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without coupons in denominations of
$2,000 and integral multiples of $1,000. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and
transfer documents and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Note or portion of a Note selected for redemption, except
for the </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
unredeemed portion of any Note being redeemed in part. Also, the Company need not exchange or register the transfer of any Notes for a period of 15 days before a selection of Notes to be redeemed
or during the period between a record date and the corresponding Interest Payment Date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its owner for all purposes.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">AMENDMENT, SUPPLEMENT AND WAIVER. Subject to certain exceptions, the Indenture or the Notes may be amended
or supplemented with the consent of the Holders of at least a majority in aggregate principal amount of the then outstanding Notes voting as a single class, and any existing Default or Event or Default or compliance with any provision of the
Indenture or the Notes may be waived with the consent of the Holders of a majority in aggregate principal amount of the then outstanding Notes voting as a single class. Without the consent of any Holder of a Note, the Indenture or the Notes may be
amended or supplemented to cure any ambiguity, defect or inconsistency; to comply with Article V of the Indenture; to provide for uncertificated Notes in addition to or in place of certificated Notes; to add guarantees with respect to the Notes or
secure the Notes; to surrender any of the Company&#146;s rights or powers under the Indenture; to add covenants or events of default for the benefit of the Holders of the Notes; to comply with the applicable procedures of the applicable depositary;
to make any change that would not adversely affect the rights under the Indenture of any such Holder in any material respect; to provide for the issuance of and establish the form and terms and conditions of Notes of any series as permitted by the
Indenture; to evidence and provide for the acceptance of appointment under the Indenture by a successor trustee with respect to the Notes and to add to or change any of the provisions of the Indenture necessary to provide for the administration of
the trusts in the Indenture by more than one trustee; or to comply with the requirements of the SEC in order to effect or maintain the qualification of the Indenture under the TIA. No amendment to cure any ambiguity, defect or inconsistency in the
Indenture made solely to conform the Indenture to the description of notes contained in the Prospectus Supplement related to the Notes, dated August 15, 2022, will be deemed to adversely affect the interests of the Holders of the Notes.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DEFAULTS AND REMEDIES. If an Event of Default shall occur and be continuing, the principal of the Notes may
be declared (or, in certain cases, shall ipso facto become) due and payable in the manner and with the effect provided in the Indenture. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">TRUSTEE DEALINGS WITH COMPANY. The Trustee under the Indenture, in its individual or any other capacity, may
deal with the Company or an Affiliate of the Company with the same rights it would have if it were not Trustee. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">NO RECOURSE AGAINST OTHERS. A director, officer, employee or stockholder of the Company shall not have any
liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
or by reason of, such obligations or their creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for the issuance
of the Notes. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">AUTHENTICATION. This Note will not be valid until authenticated by the manual signature of the Trustee or an
authenticating agent. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM
(= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(19)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification
Procedures, the Company has caused CUSIP numbers to be printed on the Notes, and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed
on the Notes or as contained in any notice of redemption, and reliance may be placed only on the other identification numbers placed thereon. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(20)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">GOVERNING LAW. THE INDENTURE AND THIS NOTE, INCLUDING ANY CLAIM OR CONTROVERSY ARISING OUT OF OR RELATED TO
THE INDENTURE OR THIS NOTE, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Company will furnish to any
Holder upon written request and without charge a copy of the Indenture and/or the Officer&#146;s Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Requests may be made
to</I></B>: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Amgen Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">One
Amgen Center Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Thousand Oaks, CA 91320-1799 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">To assign this Note, fill in the form below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" NOWRAP>(I)&nbsp;or&nbsp;(we)&nbsp;assign&nbsp;and&nbsp;transfer&nbsp;this&nbsp;Note&nbsp;to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Insert assignee&#146;s legal name)</TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">(Insert assignee&#146;s soc. sec. or tax I.D. no.) </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">(Print or type assignee&#146;s name,
address and zip code) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">and irrevocably appoint ______________________________________________________ to transfer this Note on the books of the Company.
The agent may substitute another to act for him. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Date: _______________________ </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="60%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:12pt">Your&nbsp;Signature:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(Sign exactly as your name appears on the face of this Note)</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Signature Guarantee*: _______________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annex C </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Form of 2053 Note </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[Face of Note] </P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="right">CUSIP 031162DK3 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>4.875% Senior Notes due 2053 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">No. __</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>$____________</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMGEN INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">promises to pay to CEDE&nbsp;&amp; CO. or registered assigns, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">the principal sum of <B>___________________ DOLLARS</B> on March&nbsp;1, 2053. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Interest Payment Dates: March&nbsp;1 and September&nbsp;1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Record Dates: 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day prior to March&nbsp;1 and September&nbsp;1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Dated:&nbsp;&nbsp;<B>August 18, 2022</B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><B>AMGEN INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Title:</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the Notes referred to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in the within-mentioned Indenture: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>THE BANK OF NEW YORK
MELLON</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>TRUST COMPANY, N.A.</B>, as Trustee </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Authorized Officer</P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Authentication&nbsp;Date: _______________________ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[REVERSE SIDE OF NOTE] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>4.875% SENIOR NOTES DUE 2053 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
OR A NOMINEE OF THE DEPOSITORY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY NOT BE TRANSFERRED EXCEPT
AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY, BY A NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY OR BY THE DEPOSITORY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR A NOMINEE OF SUCH A SUCCESSOR
DEPOSITORY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE ISSUER OR ITS
AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY
PAYMENT HEREON IS MADE TO CEDE&nbsp;&amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
SINCE THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Capitalized terms used herein have the meanings assigned
to them in the Indenture referred to below unless otherwise indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">INTEREST. Amgen Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), promises to pay interest on
the principal amount of this Note at 4.875% per annum from August&nbsp;18, 2022 until maturity. The Company will pay interest in cash semi-annually in arrears on March&nbsp;1 and September&nbsp;1 of each year, or if any such day is not a Business
Day, on the next succeeding Business Day (each, an &#147;<B>Interest Payment Date</B>&#148;). Interest on the Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from the date of issuance;
provided that the first Interest Payment Date shall be March&nbsp;1, 2023; provided further that after March&nbsp;1, 2023, if there is no existing Default in the payment of interest, and if this Note is authenticated between a record date referred
to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such next succeeding Interest Payment Date. The interest rate will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of
twelve <FONT STYLE="white-space:nowrap">30-day</FONT> calendar months. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">METHOD OF PAYMENT. The Company will pay interest on the Notes (except defaulted interest) to the Persons who
are registered Holders of Notes at the close of business on the day that is 15 days prior to the next succeeding Interest Payment Date (whether or not such day is a Business Day), even if such Notes are canceled after such record date and on or
before such Interest Payment Date, except as </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
provided in Section&nbsp;2.13 of the Indenture with respect to defaulted interest. The Notes will be payable as to principal and interest at the office or agency of the Company maintained for
such purpose in the Borough of Manhattan, the City and State of New York (or, if the Company fails to maintain such office or agency, at the corporate trust office of the trustee in New York, New York or if the trustee does not maintain an office in
New York, at the office of a paying agent in New York), or, at the option of the Company, payment of interest may be made by check mailed to the Holders at their addresses set forth in the register of Holders<I>; provided</I> that payment by wire
transfer of immediately available funds will be required with respect to principal of and interest on all Global Securities and all other Notes the Holders of which will have provided wire transfer instructions to the Company or the Paying Agent.
Such payment will be in the currency of the United States of America. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company, N.A., the Trustee under
the Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">INDENTURE. The terms of the Notes include those stated in the Indenture dated May&nbsp;22, 2014, between the
Company and the Trustee (the &#147;<B>Indenture</B>&#148;), and those made part of the Indenture by the Officer&#146;s Certificate dated August 18, 2022, delivered pursuant thereto (the &#147;<B>Officer&#146;s Certificate</B>&#148;) and the TIA. The
Notes are subject to all such terms, and the Holders are referred to the Indenture and the TIA for a statement of them. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">OPTIONAL REDEMPTION. At any time prior to maturity, the Company will have the option to redeem all or a part
of the Notes upon not less than 10 nor more than 60 days&#146; notice. If the Notes are redeemed before September&nbsp;1, 2052 (six months prior to the maturity date of the Notes), the redemption price will equal the sum of (1) 100% of the principal
amount of any Notes being redeemed, plus accrued and unpaid interest to, but not including, the redemption date, and (2)&nbsp;the Make-Whole Amount. If the Notes are redeemed on or after September&nbsp;1, 2052 (six months prior to the maturity date
of the Notes), the redemption price will equal 100% of the principal amount being redeemed, plus accrued and unpaid interest to, but not including, the redemption date. Unless the Company defaults in the payment of the redemption price, interest
will cease to accrue on the Notes or portions thereof called for redemption on the applicable redemption date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">NOTICE OF REDEMPTION. Notice of redemption will be mailed at least 10 days but not more than 60 days before
the redemption date to each Holder whose Notes are to be redeemed at its registered address, except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the
Notes or a satisfaction or discharge of the Indenture. Notes in denominations larger than $2,000 may be redeemed in part but only in whole multiples of $1,000, unless all of the Notes held by a Holder are to
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
be redeemed. Notices of redemption for the Notes may be conditional. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">MANDATORY REDEMPTION. Except as provided in Section&nbsp;8 below, the Company is not required to make
mandatory redemption or sinking fund payments with respect to the Notes. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">CHANGE OF CONTROL TRIGGERING EVENT. In the event of a Change of Control Triggering Event, the Holders may
require the Company to purchase for cash all or a portion of their Notes at a purchase price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest, if any, pursuant to the provisions of Section&nbsp;7 of the
Officer&#146;s Certificate. If holders of not less than 90% in aggregate principal amount of the outstanding Notes validly tender and do not withdraw such Notes in a Change Of Control Offer and the Company, or any third party making such an offer in
lieu of the Company, purchases all of the Notes validly tendered and not withdrawn by such holders, the Company or such third party will have the right, upon not less than 10 days nor more than 60 days&#146; prior notice, provided that such notice
is given not more than 30 days following such repurchase pursuant to the Change Of Control Offer described above, to redeem all Notes that remain outstanding following such purchase on a date specified in such notice (the &#147;<B>Second Change Of
Control Payment Date</B>&#148;) and at a price in cash equal to 101% of the aggregate principal amount of Notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including, the Second Change Of Control Payment
Date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DEFEASANCE PRIOR TO MATURITY. The Indenture contains provisions for defeasance of (i)&nbsp;the entire
indebtedness of the Notes or (ii)&nbsp;certain covenants and Events of Default with respect to the Notes, in each case upon compliance with certain conditions set forth therein. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">RESTRICTIVE COVENANTS. The Indenture and the Officer&#146;s Certificate impose certain limitations on the
Company and its Subsidiaries, including limitations on the Company&#146;s and its Subsidiaries&#146; ability to create or incur certain Liens on any of their respective properties or assets and to enter into certain sale and lease-back transactions
and on the Company&#146;s ability to engage in mergers or consolidations or the conveyance, transfer or lease of all or substantially all of its properties and assets. These limitations are subject to a number of important qualifications and
exceptions and reference is made to the Indenture and the Officer&#146;s Certificate for a description thereof. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without coupons in denominations of
$2,000 and integral multiples of $1,000. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and
transfer documents and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Note or portion of a Note selected for redemption, except
for the </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
unredeemed portion of any Note being redeemed in part. Also, the Company need not exchange or register the transfer of any Notes for a period of 15 days before a selection of Notes to be redeemed
or during the period between a record date and the corresponding Interest Payment Date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its owner for all purposes.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">AMENDMENT, SUPPLEMENT AND WAIVER. Subject to certain exceptions, the Indenture or the Notes may be amended
or supplemented with the consent of the Holders of at least a majority in aggregate principal amount of the then outstanding Notes voting as a single class, and any existing Default or Event or Default or compliance with any provision of the
Indenture or the Notes may be waived with the consent of the Holders of a majority in aggregate principal amount of the then outstanding Notes voting as a single class. Without the consent of any Holder of a Note, the Indenture or the Notes may be
amended or supplemented to cure any ambiguity, defect or inconsistency; to comply with Article V of the Indenture; to provide for uncertificated Notes in addition to or in place of certificated Notes; to add guarantees with respect to the Notes or
secure the Notes; to surrender any of the Company&#146;s rights or powers under the Indenture; to add covenants or events of default for the benefit of the Holders of the Notes; to comply with the applicable procedures of the applicable depositary;
to make any change that would not adversely affect the rights under the Indenture of any such Holder in any material respect; to provide for the issuance of and establish the form and terms and conditions of Notes of any series as permitted by the
Indenture; to evidence and provide for the acceptance of appointment under the Indenture by a successor trustee with respect to the Notes and to add to or change any of the provisions of the Indenture necessary to provide for the administration of
the trusts in the Indenture by more than one trustee; or to comply with the requirements of the SEC in order to effect or maintain the qualification of the Indenture under the TIA. No amendment to cure any ambiguity, defect or inconsistency in the
Indenture made solely to conform the Indenture to the description of notes contained in the Prospectus Supplement related to the Notes, dated August&nbsp;15, 2022, will be deemed to adversely affect the interests of the Holders of the Notes.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">DEFAULTS AND REMEDIES. If an Event of Default shall occur and be continuing, the principal of the Notes may
be declared (or, in certain cases, shall ipso facto become) due and payable in the manner and with the effect provided in the Indenture. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">TRUSTEE DEALINGS WITH COMPANY. The Trustee under the Indenture, in its individual or any other capacity, may
deal with the Company or an Affiliate of the Company with the same rights it would have if it were not Trustee. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">NO RECOURSE AGAINST OTHERS. A director, officer, employee or stockholder of the Company shall not have any
liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">
or by reason of, such obligations or their creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for the issuance
of the Notes. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">AUTHENTICATION. This Note will not be valid until authenticated by the manual signature of the Trustee or an
authenticating agent. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM
(= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(19)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification
Procedures, the Company has caused CUSIP numbers to be printed on the Notes, and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed
on the Notes or as contained in any notice of redemption, and reliance may be placed only on the other identification numbers placed thereon. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(20)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify">GOVERNING LAW. THE INDENTURE AND THIS NOTE, INCLUDING ANY CLAIM OR CONTROVERSY ARISING OUT OF OR RELATED TO
THE INDENTURE OR THIS NOTE, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Company will furnish to any
Holder upon written request and without charge a copy of the Indenture and/or the Officer&#146;s Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Requests may be made
to</I></B>: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Amgen Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">One
Amgen Center Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Thousand Oaks, CA 91320-1799 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">To assign this Note, fill in the form below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">(I)&nbsp;or&nbsp;(we)&nbsp;assign&nbsp;and&nbsp;transfer&nbsp;this&nbsp;Note&nbsp;to:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman" ALIGN="center">(Insert assignee&#146;s legal name)</P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">(Insert assignee&#146;s soc. sec. or tax I.D. no.) </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">(Print or type assignee&#146;s name,
address and zip code) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">and irrevocably appoint _______________________________________________________________________ to transfer this Note on the books
of the Company. The agent may substitute another to act for him. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Date: _________________ </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="60%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:12pt">Your&nbsp;Signature:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">(Sign exactly as your name appears on the face of this Note)</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Signature Guarantee*: _________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d280175dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:13pt; font-family:ARIAL">Exhibit 5.1</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">1271 Avenue of the Americas</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">New York, New York 10020-1401</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Tel: +1.212.906.1200 Fax: +1.212.751.4864</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">www.lw.com</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">


<IMG SRC="g280175g89i30.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">FIRM / AFFILIATE OFFICES</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Austin</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Milan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Beijing</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Munich</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Boston</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">New York</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brussels</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Orange County</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" ROWSPAN="2"><FONT STYLE="font-family:Times New Roman; font-size:12pt">August 18, 2022</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Century City</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Paris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:ARIAL">Chicago</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Riyadh</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Dubai</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">San Diego</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">D&uuml;sseldorf</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">San Francisco</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Frankfurt</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Seoul</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Hamburg</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Shanghai</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Hong Kong</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Silicon Valley</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Houston</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Singapore</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">London</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tel Aviv</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Los Angeles</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tokyo</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Madrid</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Washington, D.C.</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Amgen Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">One Amgen Center
Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Thousand Oaks, CA 91320 </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="justify"><U>Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-236351;</FONT> $1,250,000,000
Aggregate Principal Amount of 4.050% Senior Notes due 2029, $750,000,000 Aggregate Principal Amount of 4.200% Senior Notes due 2033 and $1,000,000,000 Aggregate Principal Amount of 4.875% Senior Notes due </U><U>2053</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">To the addressee set forth above: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">We have acted as special counsel to Amgen Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), in connection
with the issuance of $1,250,000,000 aggregate principal amount of the Company&#146;s 4.050% Senior Notes due 2029 (the &#147;<B><I>2029 Notes</I></B>&#148;), $750,000,000 aggregate principal amount of the Company&#146;s 4.200% Senior Notes due 2033
(the &#147;<B><I>2033 Notes</I></B>&#148;) and $1,000,000,000 aggregate principal amount of the Company&#146;s 4.875% Senior Notes due 2053 (the &#147;<B><I>2053 Notes</I></B>&#148; and, together with the 2029 Notes and the 2033 Notes, the
&#147;<B><I>Notes</I></B>&#148;), under an Indenture, dated as of May&nbsp;22, 2014 (the &#147;<B><I>Indenture</I></B>&#148;), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the
&#147;<B><I>Trustee</I></B>&#148;), and an officer&#146;s certificate dated as of August 18, 2022, setting forth the terms of the Notes (the &#147;<B><I>Officer&#146;s Certificate</I></B>&#148;), and pursuant to a registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> under the Securities Act of 1933, as amended (the &#147;<B><I>Act</I></B>&#148;), filed with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) on February&nbsp;10, 2020
(Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-236351)</FONT> (as so filed and amended, the &#147;<B><I>Registration Statement</I></B>&#148;), a base prospectus, dated February&nbsp;10, 2020, included in the Registration Statement at
the time it originally became effective (the &#147;<B><I>Base Prospectus</I></B>&#148;), a final prospectus supplement, dated August 15, 2022, filed with the Commission pursuant to Rule 424(b) under the Act on August 16, 2022 (together with the Base
Prospectus, the &#147;<B><I>Prospectus</I></B>&#148;), and an underwriting agreement, dated August 15, 2022, between the underwriters named therein and the Company (the &#147;<B><I>Underwriting Agreement</I></B>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify"><B>August 18, 2022 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><B> Page
 2
 </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g280175g32f82.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This opinion is being furnished in connection with the requirements of Item
601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related Prospectus, other than as expressly stated
herein with respect to the issuance of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">As such counsel, we have examined such matters of fact and questions of
law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such
factual matters. We are opining herein as to the internal laws of the State of New York and the General Corporation Law of the State of Delaware, and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws
of any other jurisdiction or, in the case of Delaware, any other laws, or as to any matters of municipal law or the laws of any local agencies within any state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, the Notes have
been duly authorized by all necessary corporate action of the Company and, when the Notes have been duly executed, authenticated, issued and delivered against payment therefor in accordance with the terms of the Indenture and in the manner
contemplated by the Underwriting Agreement, the Notes will be the legally valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Our opinion is subject to: (i)&nbsp;the effect of bankruptcy, insolvency, reorganization, fraudulent transfer, moratorium or
other similar laws relating to or affecting the rights and remedies of creditors; (ii)&nbsp;the effect of general principles of equity, whether enforcement is considered in a proceeding in equity or at law (including the possible unavailability of
specific performance or injunctive relief), concepts of materiality, reasonableness, good faith and fair dealing, and the discretion of the court before which any proceeding may be brought; (iii)&nbsp;the invalidity under certain circumstances under
law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to public policy; and (iv)&nbsp;we express no opinion with
respect to: (a)&nbsp;any provision for liquidated damages, default interest, late charges, monetary penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty; (b)&nbsp;consents to, or
restrictions upon, governing law, jurisdiction, venue, arbitration, remedies or judicial relief; (c)&nbsp;the waiver of rights or defenses contained in Section&nbsp;4.4 of the Indenture; (d)&nbsp;any provision requiring the payment of
attorneys&#146; fees, where such payment is contrary to law or public policy; (e)&nbsp;any provision permitting, upon acceleration of the Notes, collection of that portion of the stated principal amount thereof which might be determined to
constitute unearned interest thereon; (f)&nbsp;advance waivers of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law or other procedural rights;
(g)&nbsp;waivers of broadly or vaguely stated rights; (h)&nbsp;provisions for exclusivity, election or cumulation of rights or remedies; (i)&nbsp;provisions authorizing or validating conclusive or discretionary determinations; (j)&nbsp;grants of
setoff rights; (k)&nbsp;proxies, powers and trusts; (l)&nbsp;provisions prohibiting, restricting or requiring consent to assignment or transfer of any right or property; and (m)&nbsp;the severability, if invalid, of provisions to the foregoing
effect. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL" ALIGN="justify"><B>August 18, 2022 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:ARIAL"><B> Page
 3
 </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g280175g32f82.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">With your consent, we have assumed (a)&nbsp;that the Indenture, the
Officer&#146;s Certificate and the Notes (collectively, the &#147;<B><I>Documents</I></B>&#148;) have been duly authorized, executed and delivered by the parties thereto other than the Company, (b)&nbsp;that the Documents constitute legally valid
and binding obligations of the parties thereto other than the Company, enforceable against each of them in accordance with their respective terms, and (c)&nbsp;that the status of the Documents as legally valid and binding obligations of the parties
is not affected by any (i)&nbsp;breaches of, or defaults under, agreements or instruments, (ii)&nbsp;violations of statutes, rules, regulations or court or governmental orders or (iii)&nbsp;failures to obtain required consents, approvals or
authorizations from, or make required registrations, declarations or filings with, governmental authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This opinion
is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the
Company&#146;s Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated August 18, 2022 and to the reference to our firm contained in the Prospectus under the heading &#147;Validity of the Notes.&#148; In giving such consent, we do not thereby admit
that we are in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission thereunder. </P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; font-size:12pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; font-size:12pt; font-family:Times New Roman">/s/ Latham &amp;
Watkins LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>amgn-20220815.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 8/18/2022 11:54:10 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:amgn="http://www.amgen.com/20220815"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.amgen.com/20220815"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20220815_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20220815_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20220815_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="amgn_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="amgn_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>amgn-20220815_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 8/18/2022 11:54:15 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amgn-20220815.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="amgn-20220815.xsd#amgn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="amgn-20220815.xsd#amgn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="amgn_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeniorNotesMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>amgn-20220815_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 8/18/2022 11:54:10 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="amgn-20220815.xsd#amgn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="amgn_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="amgn-20220815.xsd#amgn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="amgn_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotesMember" xlink:to="us-gaap_SeniorNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeniorNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Senior Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeniorNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior Notes [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>amgn-20220815_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 8/18/2022 11:54:11 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amgn-20220815.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="amgn-20220815.xsd#amgn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="amgn_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="amgn-20220815.xsd#amgn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="amgn_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeniorNotesMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g280175g32f82.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g280175g32f82.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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H % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g280175g89i30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g280175g89i30.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MYW#AP.;XK&RI6R[V5.I-1<W6;Y5S*+E945=).^ZV\SZGB;PTR'AEX[#UN/\
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M"$>5+64DY/ZZ;P;X8.J2ZV?"_A\ZRS/+_:W]D:;_ &J\SV_V9W_M V_G+*T
M$)<MDH-K9%>RZ5%OF<%*3W=O3_(_.%C\TE2G@ZF*K/!134*?M9*%F[M<D9))
M-N_PK\7=;#P9X6TE9TTOPOX?TY9Y;::5;#1]-M!-)8W#7EE),(+=1++!= 2Q
M.^3&YWK@C-1&A0C*_LHKY?H:U\PS&NW*MC*]>2C-+VE:;TJQ<*D-9+W90M&2
MZIR3;3LNJ P .F !CTP*TVVT2V.9:)=+=!: "@ H * "@ H * "@ H * "@
JH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140015158445680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amgn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMGEN INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000318154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 15,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-3540776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Amgen Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Thousand Oaks<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91320-1799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">447-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amgn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMGN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amgn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.000% Senior Notes due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMGN26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amgn_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amgn_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>d280175d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amgn-20220815.xsd" xlink:type="simple"/>
    <context id="duration_2022-08-15_to_2022-08-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
        </entity>
        <period>
            <startDate>2022-08-15</startDate>
            <endDate>2022-08-15</endDate>
        </period>
    </context>
    <context id="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-15</startDate>
            <endDate>2022-08-15</endDate>
        </period>
    </context>
    <context id="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-15</startDate>
            <endDate>2022-08-15</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2022-08-15_to_2022-08-15"
      id="Hidden_dei_EntityRegistrantName">AMGEN INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2022-08-15_to_2022-08-15">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-08-15_to_2022-08-15"
      id="Hidden_dei_EntityCentralIndexKey">0000318154</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-08-15_to_2022-08-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-08-15_to_2022-08-15">2022-08-15</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-08-15_to_2022-08-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-08-15_to_2022-08-15">001-37702</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-08-15_to_2022-08-15">95-3540776</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-08-15_to_2022-08-15">One Amgen Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-08-15_to_2022-08-15">Thousand Oaks</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-08-15_to_2022-08-15">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-08-15_to_2022-08-15">91320-1799</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-08-15_to_2022-08-15">(805)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-08-15_to_2022-08-15">447-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-08-15_to_2022-08-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-08-15_to_2022-08-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-08-15_to_2022-08-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-08-15_to_2022-08-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">AMGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember">2.000% Senior Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember">AMGN26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-08-15_to_2022-08-15_us-gaap-StatementClassOfStockAxis_us-gaap-SeniorNotesMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-08-15_to_2022-08-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R
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M4$L! A0#%     @ 7($250=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !<@1)55S37S.X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" !<@1)5F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( %R!$E7Q-<$BP00  #@5   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" !<@1)5GZ ;\+$"  #B#   #0              @ $$#0  >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( %R!$E67BKL<P    !,"   +              "
M > /  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( %R!$E4<.&7J/P$  #P"   /
M              "  <D0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !<
M@1)5)!Z;HJT   #X 0  &@              @ $U$@  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !<@1)599!YDAD!  #/ P  $P
M            @ $:$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  !D%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d280175d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d280175d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d280175d8k.htm">d280175d8k.htm</File>
    <File>amgn-20220815.xsd</File>
    <File>amgn-20220815_def.xml</File>
    <File>amgn-20220815_lab.xml</File>
    <File>amgn-20220815_pre.xml</File>
    <File>d280175dex11.htm</File>
    <File>d280175dex42.htm</File>
    <File>d280175dex51.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d280175d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "amgn-20220815_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d280175d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amgn-20220815_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amgn-20220815_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "amgn-20220815.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 2,
   "nsprefix": "amgn",
   "nsuri": "http://www.amgen.com/20220815",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d280175d8k.htm",
      "contextRef": "duration_2022-08-15_to_2022-08-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d280175d8k.htm",
      "contextRef": "duration_2022-08-15_to_2022-08-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "amgn_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://www.amgen.com/20220815",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "amgn_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://www.amgen.com/20220815",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amgen.com//20220815/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-22-224115-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-224115-xbrl.zip
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M!.;=7=R,1L4'=Q="E53[4J8@_C_A')S]#CY$J9YC\[ U'!!5S&/(C]LKK8'
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M704'?:9S_FQ^9;8]8OZ9WTSIDG\ 4$L#!!0    ( %R!$E5U>O"67A,  .Z
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M\R;F7$G'M8JG)9P('=A'B*#Q%%LZ:$\HB!KR)S*T2$ F5!+I,POC%IMPE_!
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MP&H#+M,;[PMOI!YX> *JO &D@"I>FW"LJW"FY/=ROG[T/@^ Y&L&$JJ/5P[
M](>66EZQZQA\5B9D!#"QN50^@Y8)!FIPI+:?K,,F/G,E\+Y/I^HHK#=-0[9O
MK:V#'0&^U+UBN24\*AD%A$?(YIJ!.C.FU,6GFL+MR9#W> #*QEREAUJA$"C!
MT1LN-A;DX\+G?"Q^B4@M"8'FR-GU0>@&.HL!U(#FY'V)^41A/<!NY&!65JN+
M"1=1<TAH$%#P4_4B**YI%)0W@N5E")[2W6/N.,B,JA)3X#M&:*#=[>C=(Y'=
M])5J=L-1?D'5;S*#LG[)#"E[4=MB$F7 4F"HDX)\S)(6E2PFSVQ[H"R&$/6
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M3O9 8UJ)HFA51,[J0D?T:Q8-<(.;"9>8BJPK?!D,0(M6[O+<=3NE@P<D-!B
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M\RP"G&("S*O(P/:PK'PXGF;>(_2YPIE,)Q&Q=[JO<H.LQE"L%HD\*=T+'D_
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M5^<EU>EY=7P=$Z93VC6,MI)J65HV*MO&%=6LOC88UHBG-Q?QX"&V8+MM"Y0
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MZ;_.%=3YJ5PYBC*Z]0W6PW:=/9>DH+) PK^O\2Q9)I@7:S1%CP^9P+^79_H
MB;QX-!2Q(;VJ<EH1_]1?D_Q75N8U E1FZ)%&;Q";)GTL-D$8BXC4>#0V35DA
MIS0[B.1:87L(I6AX%XS"57K0DY5.02D5J%3^IT06O00S4\GN,H7[C(:$:_8I
M@",XL9)?O#^"XGL$3W_Z]-6G5J=87U'.4M<L@)E2&SO22@(EXJ M%J4S=*5Q
M>M.#<.OPSKFULP>U:H^JY%=+J0Q.V)9T0&7TI3ON;'%_+H&/VKM.W5 4FM5=
MA*I/ST&%@.'8='T*OY'+C B[K>SB5Z7J\>)4K0*R_33(2%W7)=!E"=NR1;0V
MRMFG&)/Q\ZBE:W<!J2!+K0.)_7EYQ5IL2>0.XCQM4J>80.SMK>C!N!3*^"P,
M@*3)(M2(A!;,6K>C3>V484>J)$6)_(=9DA<V4?X)9"@4B?N.3BN<B)6J.)WU
M8\3\$"@/ Z3(:1)6A(7]NY8[09J%7$U#U;<B(M@1BN61PO'+.KMZ2V?7S9MS
M&E*2>)#" 9F@^JZ@$L6N!F*>V9RC@L'M6',E<D3%#1%SS TV@3H-Y<CZLZK!
M^U><MHR(,9@6FJI4ISI&\0"ZZXOV*!PWT"MS4XZV'5&(DH(BJN.!<V(M$Z&N
M[J7<1[$*2&^L(S4,*\F,-K :;LXE$B?!MY\LNEJB;ZG* 2I[[ G6BODRH8HQ
MT6#EA]B9A)Q-!H3UU-R87+>#D09"TP@*.S?)^&*52D>=NW"/##")I/>':*F9
MRT,*D:I 9[,$>Z-S())4TX@1EA)/R6?3:1S.%Y],#'M!#O*C-<]#^5,ETF.K
MM9*8HG/6H[R\V)P\0:VO.+-1^Y_=? J:6S"\P*(H>,XO/QAIB/*\]*2O11F&
MZ[@I-GJ#%E0B=(8::Q-D 0^PAYD)U5%FCOM.B@"6U]E:L]);%<E)@@<N#!VT
M :BM8>ZL@2+G<FBU)-C3F&I>!!1J:C,()\UQ\5/@Y(G+,2#?06.$U0Z;TN+K
MV&U?$@7QT3?Z,V9+T6=Q_;#O8D'TFH$V#(&+UW,=B2:G<,0[#C?^$+Q!(Y*<
M]K6W'V^I0A[8G._U$ D$_F<;O]T,8]*F](9E[RO%JU,O3@F[C>^V0BB!E<*)
M.9?D:(VC<&9.&#XBI\ZN%E(9UKT7./@R=$)DK=*<OB>>*IBKD/ =\ 6=F%>-
M;"ML31!>>,B'[-94\0GZVPH/IY5H_LR4;G[%1*0)MW^K2\.:.J))J4@U1U;>
M5Q]M+T_@=L%VT/9N'&W7R\M+DEOC<SOP5"N$1FE6W7GI&FSW\#0[R!%5\6 I
M#YW@=S!BM)/W8/!2.;3C.]$N"K5V.U5J4-8^+8K><,7E&]!IW#6NI@TT1W0I
MA*0]!9(,6B)9BT"]6]$GMNQ:F$#=%^G5=/;55T!<=!A5UQ1LR1!F@TCB=%K8
M \D1JS6]2W!XR >&67!)406I=L1)O5'92,["Z'$XJU-W4"PN06H+JDP,PUN$
MTWQ>EP.]_>U;+2E6Z&RZ%),\*XD)'U.%J=/.94)(ZPEU*M-]E.JP2.E@*.]_
M;&(:ITY<M.Q!\%:T.:2Q(I3&UC %UMI,[NY5&9\+YM@\M=7'E3)P-+*5#YV-
MM;&W<E[A6Y:2%=2 @5U'9ZIY>K&LOI(!4>ZK!=]K?/:-&D;)$K"9>44];1KM
MW2GPZ[^NNVASZ2[Z"9%N.*+"N,!HR%#C3E %)?;GXDJ>A,!W,*'C( P0F#YT
M&K+8*D'L51W*;1:OE79B\=,L1/Q).&5@50WKN&M-90#R "I#M@K)5-.](=:V
MY8(3 G:D (+A.1S"44Q]$1K!#&O8L%<VF%WQ"+%UZEAM2_V9;>!9?3W*_F8X
MQ^O>$16N\.K0^GIJ>9W9<>-PM!7@M-M#)ZZ'_3O<43>*OO*2M:U6MX.KPE^@
MI6E[]9VLARF;NH;J,B#L1N*E#4,C:Q#=!Q9ABI7<>[F!GI[<8!ZBO]+="<ZU
M=PB-E!=C, N8MC4YHT0H!'W!W38Z!2Z21 H6 :;FE@<(>!,*+JY)Z59*V8\I
M":IK[] Z3KJJJ;3I6JZB0JM?<WJ:AJ)RM>=1E:],8^HER0+Y0>)TS2D NSDP
MCY22F02\F0AT$=<A^P$(+8H@35.!)K&<4F6F)V@/"HR)L,RP$566)K#FXKFJ
M.APJX"L*K/I_42L2Y/.<CB G:VA"%LO,%[-HU.JH\.['3\&E?: W4^J_W1>5
M*%Y;M FRS0GLX[EUGC7 +B7EUZ_-S;P@JJI,0<8(P(LJ(;2BL"9_M*Z$L.P<
MDIHX!>^,T+E&;\3DX;NH[W,S_NZOO(^W54\4^&>8":(0>87+OGZ+@@3$\#8D
MI/%:JF6%:4;DK#P3S,B9\%$@:NW;K(J@E;'-&IA2'_2%X5Z5%?R*UT'):S-.
MQWU(-*X+ ]LB:S4DK/>K7'"L(87+B,MXK:;1+[$?7.N1,:^HBD]2U8D=N :7
M'K/80(N73SI1,O4X>WWAR!$E6*G'9*.C"&[E?A8?J_#6&LXFE<'JM)7*2]H#
M"DW%F[4EF_AOE78YPZD;<'3M6N'^[#!%>UDBU[$M-'UOC+?*#K7+HUY3MRNO
M;1:L@"0JK%A >*N\V*^A-$345"C5[*S1;BD'P+-$=VJ5E)E="IQ>CX[J2<4Y
M[B[IN&CLW<X\./:'\-NT)-0)UY?D-@?&#>FGT 4!5^=@G(5<&U^C!?G=#FZ?
M>)%9+):<+'GTH\"07$5L7\>&]%9J$&9Z.R^K^.V4EJ9SU1V):9M&M3T25OBX
M)PCPIKJWS(;8O&%USH;W\)R9W=:I7/4EH#4!!9,/;+>AE6.13DMQ"$[S5(NP
M^@L[@;:63J"?D>294D$X4:02-'8$AGWJHS"L  $1H2LYT!9X9L?I#E45].HB
MUJ@;("!OILL-"-T@3Y6R2<?$8+365$6?T&GBC]#=VSLO5K+2QQY;EB?H0?#:
MX(+50P[F7#7&YHR#P$PJ=_">]F(0K*??K[B=HDC*;L>.X&G1IN"9*RI1';8$
M0DN@2E$+\2SLT%93=(6(FA/9/JK1N-)M12^BWVIUOIH(I #61%8O0HLPW&%T
M.^KS*(ATPX]2 ?P86S-'T:IRIUU9>=T,XT4XP=F%Q+2DT;1O-R=1& D@-M"?
M@40<_-#8+CJ2XTR$?6_<O0Q]D^H=*?)YU590XUZQ^IXK$6Q76*!YF[AKBK%4
MI(&'4"W.&^G]#^DZ@V&L5-JYV(T!JVZM2GD0;LEL,C&UO,X=4<[@BE'"\.H%
M\S9$0B,_H93=!!'7^(I*2>'':&AI^5*8HR*:%"^T4#;J,)@M"*;7;H'4B!#>
MAU'>GV6YE6NIOUY??J 2WDL0[.IG*RE4-4*L>#$<MUJ]!\.X,8G#HY52/ZPF
M3XG5J-$G-/6"M!-I\J[R_YM;R<S+?O-;4CE\MIKGXCH-*UX622_2X3F)[FJ%
M/M?)%^KI21#IAKQ6N5,Z*F6,U8*M\D/(X+#EI&EI1*9C7J8'$K.A)0JM%=:!
M=GBBVW'+KN=AOMHH80[ K$XX<)%F>4;)&Z<+DWML:DEBX623LD!CWY3%_[DK
M<*ZZFG+18(5]ZY(&,SU;:]'ZM@D@Z.ONJ:3-O%YWCVH6AK;FVP^+LJBUR(8/
MQJ "Q78?QTD(-C2\;S9Y@\W#E%# YV@*[$]A#Y%4=&,'=@<\.[#39.PLKA7G
M==:"6=S08,+<V9+Y.N='PA54ZBXAOO<Z[_P(9@T\XHHRR-$ZPD#1+L/&%YK@
M"X4S3[I00[K:RH7-CLV!X]73CPN:L_3(NG!(GH\'/NH>U3F"@PRT*CR3W7N!
M*1_7C@U,5GQ5);>KW2B +5N+6?>.2(F@]^1%FEJ 8*RPF3[+UC&2KF>Y<[9I
MWJLZ5%$Z:.>KIJ5V'!!>=!:,LV!Z7BG3[VWX55(@3QF*8U,?&V4U_,_N ME"
M=NIQ*;UK0,NFP)PBC'H/%I/>Q @%+( O(DJIUALM1*S BC02:<Y^;?03H:KV
M$/!B+]L*&]"[.TDB:;:^CYTOHC[A=K0TUJ&=BOC)D;1IQS@\G)=)C.GQU6H$
MAA!G$#END.HCB443*LZ;!&-6+N*(>QM38)A:W) CC9',2%^S@!7M#W#TC\*X
MHB?[)3O2;N*!HB!/1T&F4286&Q-Y4I4V:N6$BFP'PS+#<XCF*B:W9:22]H,<
MH2(%[*XF'I,AQ8?(IQ>)U92*1>Y26V(M:#Z.I*]R4QO3EU13RD7T+WF7-&/C
M>ZV<2RE;TKG^M6G<"\*+T8XT[)#I_&'[Y-7.I%;Z+JLAVO-0VA_'ONS+9@[U
M[92B9^40MD30*E$IG0#QR[KLMI<NNQN7^0%)3$C$5;F?BE.R@JC5=<MBT%X<
M$)T<;<8^UT6=(LKZ)>DD'. >AJ-R7K'DM*#AC Q3LU']1>ZHS9\"W?2F/B/D
MO2;3G+$C@ESWFP&Y&*IVD_H&9.7"R!4?M]GX%;. W.(!H,M8+.#:/#JKXQC=
MCKYHU++'S:SEOCGLNBV5B^*,@A1;R4RN^^2B:+ J&%>/"EN%@JV<D/L$?+W+
MK.C#LN9$_+ZQ_5^K%N;$K*2'BZ5_=3MSE!VM;=DO>NR*UB)G&'M+/#%%:Z&S
MZW-9Y$_4@+R[58#LEHJN#.#FFMBCNWP=A0/F2,%C=\#6S;7+('_DG%U2I.Z&
MM3\\IWYC]%^C"MEO&RD$GFNJ07.\V'>N#[DIPZK!YD!#7.5&*2*"7G I6>ZV
M+^6CI=5;:"%<,N70*LL^[ 97#WDN;([Z(9,10:35ASW@OW3N42TT8C588(O
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MO; 0 2QE#=.&;Z"Z'C492B_414[*[+4@8]D*5;<W'0;8[Q #VG89Z'#&HF^
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M<X*,G$N=4<&> )#M*14Y5D_ML"T$*DL4?"(LLF,\+AZ=GR(:+E;O*F?S303
M_K2%NU@(FA/DD751R4K3EV@[]/G0Z:"U,"F)(-J&H7<7!EF^9C*^HSS2C3=P
M0RWY8G34%DL[## L;'9%B4'JVI/]944Q9O1M@@&%*[L")Z0Q@TMT,.?H:+F
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M2AXTWWCF$\DVRW2&@@#ZI,,YZZTJJEDR E"6("@E 1A$>!Q5CH]<>)CS0(-
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MDR(O#F*XBABR=U%"C4"W"H.,30!Q% PBDF6D>I","V-'1.>WSXG6^>E=QT?
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M]=G7=EG]#9X,Q"_S++QO,_#M=5KUL^!+N/.)O"<-"I6M=$=(W7",5;2K)"3
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MN#YR9J5P<;UVDL8CV .O!\0M[U_V&M2A-(]0.'&(0%\)4M@'/A"Z\G$N0;Q
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MA"=F<\:S,([A0#@)Y JU#&E-.=\%2;B0G2S*+PDP-D$+TML5 :UEKFB)O$8
M$0B&V_X,SH;^RE/@*YSZ3\G@\#X?1K?))2#=V!L.4* 3.'LV /V(K!@+A:[-
M@7F2 _-\/0^,=EPQ&;'!UPD"XK1[-/JBZ"%0)"43+P,6G@5B03E@D,+GOC9:
MP.OUFJY7*#8)=:1<"Y]NU;'Q\3<X!KJ;$3*X++@) (:;\FEGS<M JPQ[/I7+
MN2&US"!GH!4%SIL[PL7M6T-6LZS7^NV&+2\&I EIC&Y=$X06W]>+H\6,@@7=
MG;%>RG:#$#("3R,0RO),-I?ABL_VB_4\V^<7Z&=LG,(EV&R=T1^[7L,J'*/M
M!@97UQ;/C&QGR=#P-H.]L7R82:&->LUA&H3DAC(]N7D(@VQ_#WX0Y"WZX>4>
M62\$H8ZO-KBE[6:8] 5!0FP(?Y\GH7-P7\/AO$U5;6O'%J*A?6U88FI:ZF5;
M #I<B8+F#((TB,/X7/(IMO:W/:2N$K)QO6;\";AD/&P7[MAG;&BVI#+RZSPA
M4[>6PV>I78!$8$Y*(QR1G82JJJN2>+,JS-QEBRAH9F2P><Q*LOSST*6L7#OE
MBEGA:NV"@B 4:,A:E/F\PAI?-0_+)(XSJM>&A*R)C)MMXXXYD #C,PMAE2#U
M$*:.N+/5N'P63*>(-SJ(*P:_8=LK9=LOUY-M=\[[[6,*9;#Y=H=%?Q?T2VG'
M8I\(".H8G8;,6O4I*3%=8:8"M.;2'6'QH+^1!1 T6^<V+RD@?J(IFM!G3/(;
MFT.T29?,&U8G"L!,FUIH\.4Q:@84E(8H)B31AR)=Y;VJ@AH>>%@5"PNG7M.'
M%<0E1,T=!Z9DCBJA5Y(N=[5$#$TFJ4)\S;T87\]X\+\=8+4H-3>]2EC0"B56
MW)$T80_P+?'L"?"B:!JS^>*W?:HWI>(C+-P?@>^1HDR!VAS>$+2-;VSFOQCK
M6G>;N46^BOT400==2+Y%H(*;*VQE5]B?ZWF%G34ZS0:%W]E76$M[^!:Z8UYQ
M?)BKATAXBPTYC7BB]1KT#K<!HC[:<A765DV^H$R)]G$EWI7KYA;@_S94NC(J
M?;6>5*HB;C]XQ^>=?O?\U.MWVR<GK2Z:D%M_422 @/,1\#A[G([98 O_/DX)
M@MKK9]$5W/](<:T;@@>RS3? %3%&AVC7(6OTS*@RB,A(*4S,*-6L1<CU'V4F
M/" H5D\4=34%L6]_L9J5:I$)063O4[),=><BB*R+T>F<WC^U?+780$;*Z;5Q
M([E&@M>@)Z)]6I?.75C)8C[#:@@4X< K<P-2P@BK*H14P( *ZZ;4/![\41;<
MVO$+V(G:RG.SE3!N^=9Q%(I5?78=92.I*PH<B K_4,$0\E>2LPNK)%&-TX*G
M47:L0J1SQRV[80\[T3#FLFPN=TPE\L(>G&NYH=QV?X%-AB3M9889EL)9TO8]
M-[Z.(\+H4;T&;/HJPD@15^,XE#X8XU&OF:D24**P1=MB*DP2+I]?L$4I+R4I
M&^A+=HBDT+WNG.HKD4YA4/B5 US4"]?V*X5\]"#1JLVC7! NR<Y4.K=9))6K
M\:A7'MOEE*_2<DV!!3[':%)?8C!Q+!3VUTLL*<5I>H59UFO-C8UB]5?GZ_6\
M.INM#ZU&#Y.AO(MNFQ,BSAI]2M5B5X?Q4&"E!CB-N7USC*DVK:V6;T6621-C
M7M$Z$=F5?QVN"=]O1>J3(<,\%S"A6U(L9*S#;Y> JCNU_(A3,CZNJ<9B.M$
MO";:8\;I$1LWZLKS&?;6\T!@,D.W?4Q)2,?G(#LV.OU>\20HN6*)>S*:4(27
M(C8J=ZI*R5<X48M.?ALEO?RMDAE4QU4MR*VOJJMB92"J/\T%@(;S3(_-JE1]
M9\14.5X11P0A 'LDEC:L.LI]$@+XC.0E;%_:RX.8EXA*5^T, JQ#A&%$;)L3
MA.\%,S'##9,K($,\T),P4V5EL'@69L&KY="%,V_".SSBO@E82C,> $G[+(V[
MY:5%@L.%LV9(ESQ-D78=OK?7O^CR]9(Y5O3CT"X4]5'\07F Z<# >[,)5?W-
M?F JMZ.JDBUT""\A,O83LS@U+1>TV5SGJV-?:YJ/U6Q1XBXEIO;\BKS48OP"
M'"_+XH]H_3I(:9CB_5EA)D>OH9C'513B%=;/J[" 2S2*%0'IF!AM9P.TY#R#
M$T,RZZAH:"K8\K$#$V%5C$C!QI32KHSMJN(F!T4B3LU53DK(>)XE$2KO6*$#
MY'8\8Z#-I5DN9=;I*.O9Z*H,146SLE>5TT8*:/!56,TX)%%>+&*@(,;!+3D?
ML9[<S"JV5YBQZBD)0]8RU7+9 (82GFL67[FV+?<F&T/HQYSJ>I4\G,K_4Z\I
M,_'&2?'+,;MU=U+,$^UBLPE3T6NA\+1XX7:]1IRGKAGE^PY$+G<I5UK&)RHG
M1Z)5 CD=,C"Q43@>U'H-E:%YIBK;2%N5V7Z:8[BEK!<DX6TN\]5>YFN:T,:H
M!(A2TCI3V .BBY0RSRPV+O?GC,1]NCU1Q,6"BQE3.>;!<09*OKO(X[PAKJ<B
MKC6-L&^<M3I-AB?I75Y<G+;.5*C]IP8HO]U=U":5GJ-4.Z/%^ 5MI<J!K*L?
MDNIEE<>6.EBDN.56R):5E:)#8 )H[1\IA:P]R*$PPPK'%5X%+I2*Y=+1K7@5
M8VIFD$N8+EX#I21O&'7K1D+XK=^*]B0JT*<L8MIQLGQE;@/0JQ^V#JN=_J[W
M2:3]PC!,7H+A+ _8<XRCY-KJQ3U'*F*U%DL7#Z*K.<6IHO%P.!.C!'2/7"T9
MWKWE2MFPTE)"L8% S3#JOTK1/&\Y-8KT ^)O\\2JAC:R_$0CMO=1?CU5GIS&
M4K*@_ &U"E]X5_, Y 4J9;NX8"=E]H4T/_TCM9!3GA/[L8JY@4JC5_4Q,R[C
MFU=5[M;#,:91>#_4EE&)A=2!'(,P"<=1%4&YX[.7N!#%"$LZ#$&<"?5GUL,1
M%VH,LKNWA!=361?T-IW'H\K"H,:=53E;74]Y;J+7%A8*+>P^-F273,/CK>NW
MTU-2<DG^6E!V4?94QA!2T@WJH 65S#KD-(H0QZ"*R12'% R1<^I!3:<IJ,TD
MXE7-GR+#*/<[STTQY6458]D:AQ3"U&VE(VE'\L*:C&Y1O]+01Z#ZDWHMTB]'
M&]*@\I)"CF,W3D.$HI71O_4X"+!(<J+\3A0ID].J=8P-$P(F+>U8<0F=6XJO
M.8:V\JS,RE+B1B?E&XE6_=O8D<S29NM<7)&+O-*LJ-1A802R1[:%CEWEL&7B
M3C$VC8LLI9V=HR%7<<YB-4!Q<U1DO[Q0V2\JF%1T)2*+BN.GO(KY,B:QD0]7
M+A^N:4)9L_6A<7G:[TGV)2@@[5:/@C[@6+=4&(V2BQADAJK($R_B\$&0.>;:
M$>UD+SMR X4HCD(02%"?X<3VQ/CI,-S"EQZB:9XB*@YIWL!)PFVJ?!-P?!A=
M37*:8%J)A(!H5B-L9(DQ<4/LJR7V-<VP(G#!%N(-PI/.28\ 5!78(&O<3M:P
M2S9$KA'=A:,(* O#053^+IF857:NS]0^"N$%391.QJ_7&(^C.+*RG$P2E[R?
MPR6F9*=("5D4(Q2-Z0?$K4*A2T:\(>I5$_7:YI\ WSX^OT04Y<9)H]WI]1G_
M$MAXPQN!S 5L%('HV,'H>R$(9NE=R%6?9^GPR[56 &U*9$Z,%$94!S]AL)SR
MW(X5Y8/ ?:4=1DX#Y@CI&)"28JF:@4LAFB"V&.6\^>RO8@$X'?L;3\2O=]36
MW1,!A#= [UV0D[3N"X:.3<Z9Q$A01 7\M.NUK#RKP9UH>V1Q89LL&7R4ZY_"
M$G*3+ZX/#]\T]&YFOTN>6CM1GE03Z"MPLC>4VNOF\&[X_ZKY_YHF;R"Z,L(O
M'S<X;:.O$2E)0T0&#G(WA2T+%FH!IO)."=(HT.2ZR+L0EQ*(B%'7:]:W&LAI
M0WJK)KTUS<AH'!UU6W^U.0QEUSN&W^'5#!CC !;D)A)&*M9PPJ4672Q!Z98L
MSLKZ3&*Q@%.'PHV#_(W7;W500J_7MOZ&,?=D$Z6PSLDD3;9]>HXN#>NQ4#1'
MI6*T%[SV]SZ]"6_] TUR^EVVM:&8C</)Y]E-=)-F^74TU8']B ]7T?$Q I5#
M>S3K410D GIR^<?)'V=_-/#191*1M>@D&L_(C7P6)="XUQC.MC>QIRL_-6L:
MC,VEA3N79T<DHU]8Z10</#!!\V4@D ;I9!Y?V8P:Q&NR3U,NA*(PP8*[\]HH
M7&MC:;UVH<W[;OP$8C0/ SJ2/!Z.<%3!#FC%L4!_Q1Q9%74%311:B$S*N)M^
M2FXI"N),(K*@0U]BC22S;19.89PP?IZ["ID,-!!=@(:G@.'D..-#N@PC4L I
M@HP&KL&T3>9XP11+02052?J^DLC8]R>\BUQ((TX%EY99YX^<]=8#DO<Y3G-A
MG/GF@GPJJ.(U#3,_.?^KU:6Z/*>-3[N%RCQH<:7Z)IWS?LO'@IJGETV"P\,:
M(J>-]AF6KN!<1RR2]-EK=-L]*O)SV<<T2*I0<MKH4T&?>LUM'9,\3..]CXW3
M4ZQOPR/BTAQ4,*?QJ:?*</3Z6+'$*J7W +I=?1FDZP+"D8K>9%2]>DT$"$H"
MN<V0,R;D;"+T5C$+4YPKHT0@!YK>E;U(\.H?HF MRX;\0>4]K,I4[]KONSP=
M"X)CA%@@*:*18N;:LEJ+JZB798I _.".SQ.8-_?.5A6OF6'JPH\=11_H*4?2
M.@^^P*UXW/!>[Q\>[.WL__GZ]8\N7=9 >L>KYPWLQPT0"0%1QB)Y;TK4/4T-
M^UX/?CJ3LE!G/Z:0?3\5=<C3-29\;XP<4'0H$OP(?Z%T_I]$FGA@A='7/ZO"
MZ/YC2XR^^GDE1N%:_M1M7+S?:DM.9)KQ_V[=AO(+;[[\.QE)MJ4$-:O<RRCG
M?R%UR&_I VJ7;BJ8?F\%T^4K5^0=6^TD!^E!VS642!&'5T%,1I!MF_Z6Z@7?
M7BO8M!*#UK-S':*9X\W^[MY]#>$NW;.K=D<_\+I;M*!Y"K)('L)_H0P7?/7:
MN\U=T.]VMY^P^+(]S]6NZ&:\F_$N&.^J#]@%&E#H%-U-P](Y0Y;EUVL"&4CZ
MU?]&4U"I1F'II#VY1$19B%D6WJ08G7JGPBL7%6A^Z'_(NJ22A4P]+U7O*DV_
M*->V3N9F#QY7L4"=C#*.H]F<,GXDWS E]'9TVEU'DY4KCN\7UZHNJ22/D Y)
M/!>2(:OYLV\7&%_^:('Q84+BX0(A\?"G"8GO/Z=SD?1ZRBWW*.%.S5B$S_^+
M8IY:JB=8QO=;N"M>^!7..7*CW+N#_6+7%K F52V25+5 @9D*=ZD4^UA/7R63
MT&3DG:A\AW];5.!^F27C:4;S;]Y%@/D>T33@:D#L_KA*J)AMQ5B]LW 4Q#$:
MVB^R]"H+)AA&*I9XX[F67 XT^G,X/L:+B@M!7!?B?JOFBFLM:6]L.8^TY21)
M^-4[NL^&LZ+>/Z#-!AC!P=[A(8L9UC@V6_N(Q?W/#\)C<57_JW2Z?X9\_A N
MN?_0>8JTQ:[6O</]_9<'S;^_7#F3KJ#AY[L'6!^@%R:(-,@.5HS.)YI6Y/R3
MC)%,N:L2+HN+L<0X^>K%=QHG?Y:LV4EW01!XM.GP-UN$N,>V]0-HM7%VTNJ@
M:W7WQQCMBY7-X7^.6\V6+%TPF;[UCL]W;:P*2MU'V27W5R]QN0DZ4BT%EJE*
M_&OB$>GV<-E0C#T+LN&UY*#Y=-;+(M23C[<2*"-_XPR&"V>"F!=BZ(7Z<>5#
MZS+*APQH_\6[WF4%Q_OSQ>]OO1MT( ^#>(<NQS=T3F;7[_Z +]Y3$5]=.6$-
MYH43&KUQSCH<(U7<GI,/B2;^F866)[!R//]9;K%7C_2*O=[_>5XQ6 U8V@YN
MMLN]F7E7&PJLAJUV/[;:)Q_[T-*!.TOK=]/=P;.?X6TZNGN -6?CI/MV)]W"
M->L$$[&@_3)#[D>SV![SP\Q%9,*HN@OD)V1U;P[@;IJ%7V<[$45!O=G!'ZSI
MW)=6@Y$P5,N'\O^==%^[ .)W:-E/.TJ)E\! ,&ATPO$R,#8=_/7FNZY5>Y"'
M]PSR_B,%[ YC\(X:G7^W0_"\,[A>SCOVC?N]"_DT8\046I4RR^5V<6P^FC]5
M6/#3>=A^G5OWL;$HKW]>+,HW!\7:1+6_NT<RG$-8ZL=O(BZZ#2^^DU5N/!O?
MX-E8]L9ZT$)C/KM.,W(#2##N_<DR#[G]OGD0*M5-E4Q9[&6U/";_E"K1#[/C
M=EL8[-Z"*38Y&/V\WRK;<U=OJE=FSE8'"R;@*'I>\[+EFCE_A.G5A,)C/'^O
M=4QE&SSX=\,[.3T_:IR:'Q'0HMVA:/ZS5H,R#R2XWV0&?&QU6^U.XP-0@]=M
M?6AUNY1 0/D(T&BW==+NP3/X45KJ-,Y:JIEFZ^*\U\9:8?4:+$O#(R#J5L7S
M7:\T7H5.33?Z!_A<'K9;R[IM>(R0R:@&\*C1*72%R0[M?L^,I7/Z6;5RVCYK
M8X;$<;M[?'G6ZV,1#,3:[!UWVT>F,[T\/JW#6>,S;CEF3"AP;1P93*!UT:_7
M&KCVGSZ>PS0DC\(:#"[EXF7Q\8LES_'S\NP:'9[\XL_@I?)0Z,O/7N_R^*/^
ME(8'O\ R].!YX6V[!_K,>K=>LW?W!V5":.J_[)S"*)BHCEO=?OL#ICRWD*XN
MNJT><C?*:@'JP)3H\RZP2(0TDH<-JO50L=RV0*L6O]WK7<)J,UG!=I](Z+=0
M:9<R7JFQ$O(Z?G31^,R0FTA*E,WCC!?:ON>D5=F,<3 =WA.A!7P9*)%:^H_+
M5N\I%F!+AEROR22(7<!DH9>S1I/(9\'HX(DU.DQ)AU/_Q./;]FD]S;)?G+::
MO.C<[66/&1RT@_L%XLVE>?JIW:,#RX/%AH2SP! _=<\[)Q\N3^NU7AOKY. H
MK TB5%YIV:]: =_[B%P!S57X1:\O?/;''Y3C8!K-X/Y&Z8FQ#RG-DTO>F#)C
MDS!($!)?Q?B-".$1GDS*8'^V.D\9!ZKB+85>W$9Y2*!(!"A0FO"3^/_^SZ8V
MKFD%"D7ENYY)!O.]P&N&<7 ;4!FI;)H*<HE;D4UB**V2:U2GSO&;6;70&(:R
M&@A7Q6H&,T_$M2E!JB3SB3>&)KV"XT( ,"88)Z2!6)SL0J=S5?HM#R?1#K9*
M!64P4 D.@X1WW>^R@9%2K:H[^(1J$T86["FZ?Z1@:N =S?.(:F<U ZQB*%-/
M0)UBE-"0H'[MM[PM;!ISELWZ5CK-K-7>-?CS3I(TS9_KTO'B$9=(<P2G1+E8
M5QN_O8Y@Y'J5,)5\@-#W5,6.8/T0_'+!"[YI>R3X9PK0YJV&[,.)!XQ?.8XR
M:*)R3@)1-0A+SLF#0],6)HQ*!1"LZC?&K,'R^[[4*,]"WHXR3K0P1:E/2^/6
MQ3<I,MDF2/C? LI*97D FZ^J>E$4*\CU?73"?9$$*I?#-RO."V/O):?+/Z09
M/A2ZJ2Q02#($]CB9SBU<@$&01X)?_>[#.0@+2I6\CF;A3CZ%J;Q)TMLL  9U
M^')O!ZC]W1_XXGLZ#72(;\,8,SCI<[A\ES3@?#\,8D1)P$*8R>QZ W^T\A3[
M];R'SEH@2391;!1Y]3Z>[K"\+4:Z5[C:H2G"N:T"1B_"+,=4VMOKM%X+LHJ:
M#!:8M/"L89QR0;*!8M72*W)[8D-P:E3E$>W\?_!!][9NKT-B:5SIU;E)W%L$
MKE9$#T?F9%73I?L9.6Z,T2?$$:7(JUNYA,IS(VPKU4:A5Q9PGE#7"M] ]?UR
M;&'=H?H6EI\_V-T_+",Y%.'3RX?;KHZFKC:%*\QH,Y:XF5B5>>5\,Y0FH<I<
M$6YX ?E2H9=SC:UZ394PIEJ1(D<<I5DZO[K&3\^"!'C"+$@$H@=Q?$B2G(F
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ME*O%[B3CJY#"2;E]<^!]YZKE6Y%EU^3B:\!2H)'!+!QQ%)S-->'[K4A]HJN
M U?@4FMX"N@NSNT"Y LE0"H92S8/+"3.G!*C5:6,$WUG.A'UQ@[YF'%^Q,:7
MNO*$AC6MU839#-WV,64A'9^#[-CH]'O%DZ#DBB4^RFA"85Z*V.)H$LU41=D*
M3VK1T^\;-E[QK9(95,=5+<BMKRHUPRFA K84"P9MSS,]MM,HY)8EZH#%5#E>
M$8<%37%JJH0:'!?N$PV,5'\';JA4MY<',2\1E;/=&03#+QQ+Q+:YO%Z3J-*J
MF9CAALD5D"$>Z$F(9CGJ'&OA8E:^4YR7J\G=X1'W3=02/.-ZNBCMLS1. -W
M5RB$1$EPN'#6#.F2IRG2KL/W]OH7G;]2ZHWCNU#41_$'Y0%=#(Y:K-?8A*K^
M9H\P5;]3]>T6NH:7$!E[C%F<$O\>NRHVU_FJV=>:)F0U6Y2YR[58_8K$5#OH
M%8F92JQKBS\5$]*ETE*\/RO,Y"G(RF(>5Z&(5QG(MQ46< E)L<(@'1.C[6R
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M^%#HIK) H041H.=D.K>P'P9!'@D\N1.5#!0R"W?R*4SE39+>9@%PJ<.7>SM
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MS2M5[684Q@B7C25#-5XF&E#@J+F#6]RT-5HS02P6U,>I&[7)KOFML+MIW0T
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M8#)*^RR-$Q0[\!4*(%$2'"Z<-4.ZY&F*M.OPO;W^1=>OU/+CZ"X4]5'\07E
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M4W;KGJ28)#;%Y@JFD=<RML!DX9J>'^=I.8SRSS9$+N]2VG91&O(WAI8CJ)5
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MAI,HFM[ ^%M)R4@J2-*9]4ISK:WQFMC8V[UW9\<?Z>#[?K=S^#=02P,$%
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MSMI\VVZ35CEL$( .EN2 !Y<8'LH0'BT<T"&+HIS=^F-SJAY%D%KN2U'FWF+
MH9!BH'*NC,,U&V0)*)$;<W7X*=7WM57*!F;;Q$A"#J(50/$RQ^GJVK]L1#;@
M*6:$!)-XEJ<V?%8+@\G8#W-4N=1Q<0_&X%FU0CX'Q81),)J24)-X&-Y!5/G
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M8,M(HP,,A*]YK-M-*GM#Z+: "U],-&R!C %EB(?$-70D:1*C[\40T1X;)4D
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M$4&TI2B:CC8!$B41B%%$D*E2D%;0[TDQCBD0U 28.P-\$$,BDUF.1<-L"9H
MO*]E,N -:7H4X<BRTN@@)0B';@K5@# 2N((W!R \1G]& +Q5#:1!YIX3Z@@W
MX%$<XNOP@*U]QQ-G'"L-^H;)% E&P%#$"#G1DIQ@+;CFM>YE]-*M^M92E0'*
MP4I#Z::G"')3RC"HH9HG*A9WJ1Y+LJ% 8SCN9A]><"L3$0O>M2%6;@\)(Y(T
M,O4T)(;Z(D*AN!O29CCM)V$HG-(.>0H*OON@;EZ6)^T:^ U-.HA0F9@! H%U
MBW28)51UK3/DL>!*ZU;[J<6.(,C0"A),=1DD*^G,'7(9:2\G(WG6<",H&::6
MDY> ?N($T 7X1C)!(0 D0BQCU(QA9U*'@)2!$ 35ZK:F'HF99SKGAU!M,N-9
M&>92W.,K_FZES.1%L% 2#'*L')JQ@VIE8V0COI0#4B,/0B(QY:-<%'VA7<8V
MQF:5$UK(O;B%FI'**65T49@+$E$>V<YYSI]M-!R4!=J-5H/W"+@HC69T/<4R
M0CM1H2G+ &K+VE6C'*#\U5 F,^@F#T J-%:E/#?EYK>4=2;)C%HK+#1X5H /
MA<L<PD?ZPRMDLB(]:';+V#*)A'(WE-%1;%MSBR5L,T#\4/A HPEUQ^;ER$D+
MJ0 [F?0/H&5H*Y:W4'46X7JUH@'$RS#QOW&8V'X9)OZ48>(#HQR<TR"0*# 0
MU:2YNFN.5.\_X"N0K#D:M$5N"DEW^12CFT >Q2*P>!"VT,B6?;)7-+4+W:MI
M*Q%@$FK2(Q-W+CC7&A:8J)"QX,5%47-])V"(AQO/[]U\55\J.)1R32>ZOS$U
M4!7+!/6HNG-P4)81ADIJP5<I&D\?UTH;B:H5B;@Y,PV?&5?@\8\M<I@S_3'5
M<,_@.@3&IJ_PR@.H5#=24%AR4_[+IG JD[#<W\("J$/0J.+_BFEU6O8H\$%#
M5J0&0 "41E5?N7T0-%LA>"_5D&1 W8^!(($- U0ECD-!+2EA8^MS9L.A2B*2
M#.%[N=H]K2:D!)A)E3P.)?9W>@KFS3-JZ*-Z?_ZPV3UB(&,C^*$L,8#V=8@#
MK]6'#/>=W();F;[4'1"#UP!1[738$ZD4]82H, MU!Z,0G-&SL*=[I.I.1:ES
M*G"!_:MFB 2^"!>;D #:!'J>;?L^//2/(9/HOS&GJ5<K"V^N.*\;/' LLE<>
MB\R?K-IJ2@DQ,2<R (T$AC3Z(?$&6\QU/OA8>:[AG+0 CJ8@U>GSLVWIY\XL
MS+LRO9B-),W(S0%"F>>#A,*8$A2&< !H&\_8(6W,](2\&!!G@+(4;6#M!#UK
M6NI7IF44:#;GNK9=QRYV3$QQ;.9#3B@74SM[E$[L$<VER'!^H+VSQMNJWQ-@
MYA)"L?WMQT88_KX$*B15O2<$]WI[OTG?L',.5HW8KSR:0%?TA6<WD'39^?GE
M V@9*O!%]W>X2'^S]#]02P$"% ,4    " !<@1)5TK:Q:.H#  !R#P  $0
M            @ $     86UG;BTR,#(R,#@Q-2YX<V102P$"% ,4    " !<
M@1)5*TM*A\$%   K-   %0              @ $9!   86UG;BTR,#(R,#@Q
M-5]D968N>&UL4$L! A0#%     @ 7($25<T!+2"Z!P  [%4  !4
M     ( !#0H  &%M9VXM,C R,C X,35?;&%B+GAM;%!+ 0(4 Q0    ( %R!
M$E6N(#.8=@4  *XW   5              "  ?H1  !A;6=N+3(P,C(P.#$U
M7W!R92YX;6Q02P$"% ,4    " !<@1)5=7KPEEX3  #N@   #@
M    @ &C%P  9#(X,#$W-60X:RYH=&U02P$"% ,4    " !<@1)5I=E$-+Q9
M  #M;0( $               @ $M*P  9#(X,#$W-61E>#$Q+FAT;5!+ 0(4
M Q0    ( %R!$E64M<J]_GH  'VY @ 0              "  1>%  !D,C@P
M,3<U9&5X-#(N:'1M4$L! A0#%     @ 7($257'??0TA$0  NE0  !
M         ( !0P ! &0R.# Q-S5D97@U,2YH=&U02P4&      @ " #^ 0
&DA$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
